EXPERIMENTAL FACTOR ONTOLOGY - ANNOTATIONS
Term: ovarian cancer
Accession: EFO:MONDO:0008170
browse the term
Definition: A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.
Synonyms: exact_synonym: cancer of ovary; cancer of the ovary; malignant neoplasm of ovary; malignant neoplasm of the ovary; malignant ovarian neoplasm; malignant ovarian tumor; malignant ovarian tumour; malignant ovary neoplasm; malignant tumor of ovary; malignant tumor of the ovary; malignant tumour of ovary; malignant tumour of the ovary; ovarian cancer, somatic; ovary cancer
broad_synonym: ovarian neoplasm; ovary neoplasm; tumor of the ovary; tumour of the ovary
related_synonym: ovarian cancer, epithelial; primary ovarian cancer
alt_id: MONDO:0008170
xref: DOID:2394; GARD:7295 ; ICD9:183.0; MEDGEN:216027; MESH:D010051 ; MIM:167000 ; NCI:C7431 ; ORDO:213500 ; SCTID:363443007; UMLS:C1140680; icd11.foundation:685124533
Q
GWAS1428997_H
high grade ovarian serous adenocarcinoma QTL GWAS1428997 (human)
IAGP
rs10069690
1.0E-19
GWAS_CATALOG
PMID:38723632
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1428998_H
high grade ovarian serous adenocarcinoma QTL GWAS1428998 (human)
IAGP
rs10810671
7.0E-10
GWAS_CATALOG
PMID:38723632
NCBI chr 9:16,914,837...16,914,838
Q
GWAS1428999_H
high grade ovarian serous adenocarcinoma QTL GWAS1428999 (human)
IAGP
rs4149419
3.0E-8
GWAS_CATALOG
PMID:38723632
NCBI chr 4:69,726,524...69,726,525
Q
GWAS1429001_H
high grade ovarian serous adenocarcinoma QTL GWAS1429001 (human)
IAGP
rs7851336
3.0E-10
GWAS_CATALOG
PMID:38723632
NCBI chr 9:19,030,885...19,030,886
Q
GWAS1615683_H
high grade ovarian serous adenocarcinoma QTL GWAS1615683 (human)
IAGP
rs895412
1.0E-7
GWAS_CATALOG
PMID:38723632
NCBI chr 2:113,216,387...113,216,388
Q
GWAS1633771_H
high grade ovarian serous adenocarcinoma QTL GWAS1633771 (human)
IAGP
rs12982058
4.0E-6
GWAS_CATALOG
PMID:38723632
NCBI chr19:17,298,571...17,298,572
Q
GWAS1633772_H
high grade ovarian serous adenocarcinoma QTL GWAS1633772 (human)
IAGP
rs7833298
1.0E-9
GWAS_CATALOG
PMID:38723632
NCBI chr 8:128,068,411...128,068,412
Q
GWAS1018480_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018480 (human)
IAGP
rs11200014
8.0E-35
GWAS_CATALOG
PMID:27197191
NCBI chr10:121,575,416...121,575,417
Q
GWAS1018481_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018481 (human)
IAGP
rs7931342
4.0E-14
GWAS_CATALOG
PMID:27197191
NCBI chr11:69,227,030...69,227,031
Q
GWAS1018549_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018549 (human)
IAGP
rs73110464
2.0E-15
GWAS_CATALOG
PMID:27197191
NCBI chr12:52,918,828...52,918,829
Q
GWAS1018551_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018551 (human)
IAGP
rs11571818
5.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,394,673...32,394,674
Q
GWAS1018552_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018552 (human)
IAGP
rs11844632
3.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr14:68,559,662...68,559,663
Q
GWAS1018620_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018620 (human)
IAGP
rs11907546
3.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,131,991...34,131,992
Q
GWAS1018623_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018623 (human)
IAGP
rs2300206
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,002,002...34,002,003
Q
GWAS1018625_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018625 (human)
IAGP
rs56084662
4.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,295,727...32,295,728
Q
GWAS1018680_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018680 (human)
IAGP
rs11119608
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:210,816,167...210,816,168
Q
GWAS1018681_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018681 (human)
IAGP
rs75316749
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 3:169,043,635...169,043,636
Q
GWAS1018745_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018745 (human)
IAGP
rs4604234
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 6:80,398,959...80,398,960
Q
GWAS1018828_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018828 (human)
IAGP
rs11907546
3.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,131,991...34,131,992
Q
GWAS1018829_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018829 (human)
IAGP
rs2300206
2.0E-8
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,002,002...34,002,003
Q
GWAS1018928_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018928 (human)
IAGP
rs481519
2.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr 3:27,285,723...27,285,724
Q
GWAS1018929_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018929 (human)
IAGP
rs7725218
2.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 5:1,282,299...1,282,300
Q
GWAS1117389_H
ovarian carcinoma QTL GWAS1117389 (human)
IAGP
rs7705526
8.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,285,859...1,285,860
Q
GWAS1117390_H
ovarian carcinoma QTL GWAS1117390 (human)
IAGP
rs7405776
2.0E-10
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,733,029...37,733,030
Q
GWAS1117391_H
ovarian carcinoma QTL GWAS1117391 (human)
IAGP
rs11651755
8.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1117392_H
ovarian carcinoma QTL GWAS1117392 (human)
IAGP
rs1879586
2.0E-19
GWAS_CATALOG
PMID:28346442
NCBI chr17:45,489,971...45,489,972
Q
GWAS1117393_H
ovarian carcinoma QTL GWAS1117393 (human)
IAGP
rs7207826
2.0E-17
GWAS_CATALOG
PMID:28346442
NCBI chr17:48,423,311...48,423,312
Q
GWAS1117394_H
ovarian carcinoma QTL GWAS1117394 (human)
IAGP
rs4808075
2.0E-19
GWAS_CATALOG
PMID:28346442
NCBI chr19:17,279,482...17,279,483
Q
GWAS1117425_H
ovarian carcinoma QTL GWAS1117425 (human)
IAGP
rs10962692
9.0E-11
GWAS_CATALOG
PMID:28346442
NCBI chr 9:16,915,876...16,915,877
Q
GWAS1117427_H
ovarian carcinoma QTL GWAS1117427 (human)
IAGP
rs58722170
1.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr 1:37,630,749...37,630,750
Q
GWAS1117429_H
ovarian carcinoma QTL GWAS1117429 (human)
IAGP
rs6005807
9.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr22:28,538,325...28,538,326
Q
GWAS1117431_H
ovarian carcinoma QTL GWAS1117431 (human)
IAGP
rs10069690
1.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1117432_H
ovarian carcinoma QTL GWAS1117432 (human)
IAGP
rs10962692
1.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr 9:16,915,876...16,915,877
Q
GWAS1117433_H
ovarian carcinoma QTL GWAS1117433 (human)
IAGP
rs1879586
7.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr17:45,489,971...45,489,972
Q
GWAS1117460_H
ovarian carcinoma QTL GWAS1117460 (human)
IAGP
rs17329882
3.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 4:119,028,805...119,028,806
Q
GWAS1117461_H
ovarian carcinoma QTL GWAS1117461 (human)
IAGP
rs10069690
3.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1117462_H
ovarian carcinoma QTL GWAS1117462 (human)
IAGP
rs7705526
7.0E-10
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,285,859...1,285,860
Q
GWAS1117463_H
ovarian carcinoma QTL GWAS1117463 (human)
IAGP
rs10962692
9.0E-36
GWAS_CATALOG
PMID:28346442
NCBI chr 9:16,915,876...16,915,877
Q
GWAS1117464_H
ovarian carcinoma QTL GWAS1117464 (human)
IAGP
rs8037137
5.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr15:90,963,407...90,963,408
Q
GWAS1117465_H
ovarian carcinoma QTL GWAS1117465 (human)
IAGP
rs143663961
1.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr17:30,854,202...30,854,203
Q
GWAS1117466_H
ovarian carcinoma QTL GWAS1117466 (human)
IAGP
rs1879586
2.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr17:45,489,971...45,489,972
Q
GWAS1117467_H
ovarian carcinoma QTL GWAS1117467 (human)
IAGP
rs7207826
8.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr17:48,423,311...48,423,312
Q
GWAS1117468_H
ovarian carcinoma QTL GWAS1117468 (human)
IAGP
rs4808075
2.0E-17
GWAS_CATALOG
PMID:28346442
NCBI chr19:17,279,482...17,279,483
Q
GWAS1117470_H
ovarian carcinoma QTL GWAS1117470 (human)
IAGP
rs6456822
1.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 6:28,512,858...28,512,859
Q
GWAS1117471_H
ovarian carcinoma QTL GWAS1117471 (human)
IAGP
rs10962692
5.0E-64
GWAS_CATALOG
PMID:28346442
NCBI chr 9:16,915,876...16,915,877
Q
GWAS1117510_H
ovarian carcinoma QTL GWAS1117510 (human)
IAGP
rs8098244
2.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr18:23,825,589...23,825,590
Q
GWAS1118995_H
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118995 (human)
IAGP
rs10500780
5.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr11:13,401,400...13,401,401
Q
GWAS1118996_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118996 (human)
IAGP
rs1564271
9.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr10:26,722,183...26,722,184
Q
GWAS1118997_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118997 (human)
IAGP
rs10899426
9.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr11:78,008,566...78,008,567
Q
GWAS1118998_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118998 (human)
IAGP
rs4618572
9.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr 6:1,492,427...1,492,428
Q
GWAS1118999_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118999 (human)
IAGP
rs295315
8.0E-7
GWAS_CATALOG
PMID:28935272
NCBI chr 3:141,643,383...141,643,384
Q
GWAS1119000_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119000 (human)
IAGP
rs17693104
8.0E-7
GWAS_CATALOG
PMID:28935272
NCBI chr10:80,608,465...80,608,466
Q
GWAS1119001_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119001 (human)
IAGP
rs868767
2.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr 3:141,658,488...141,658,489
Q
GWAS1119002_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119002 (human)
IAGP
rs2050203
4.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr20:24,451,198...24,451,199
Q
GWAS1119003_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119003 (human)
IAGP
rs17548007
5.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr12:102,981,636...102,981,637
Q
GWAS1119589_H
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119589 (human)
IAGP
rs10899426
2.0E-7
GWAS_CATALOG
PMID:28935272
NCBI chr11:78,008,566...78,008,567
Q
GWAS1119590_H
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119590 (human)
IAGP
rs6256
1.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr11:13,492,506...13,492,507
Q
GWAS1119591_H
progression free survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1119591 (human)
IAGP
rs10832063
5.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr11:13,553,087...13,553,088
Q
GWAS1144562_H
ovarian carcinoma QTL GWAS1144562 (human)
IAGP
rs192503876
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr18:65,045,831...65,045,832
Q
GWAS1144563_H
ovarian carcinoma QTL GWAS1144563 (human)
IAGP
rs80314337
5.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr18:65,221,472...65,221,473
Q
GWAS1144564_H
ovarian carcinoma QTL GWAS1144564 (human)
IAGP
rs11873753
1.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr18:75,985,500...75,985,501
Q
GWAS1144565_H
ovarian carcinoma QTL GWAS1144565 (human)
IAGP
rs137657
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr22:39,337,237...39,337,238
Q
GWAS1144566_H
ovarian carcinoma QTL GWAS1144566 (human)
IAGP
rs7671115
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 4:164,203,350...164,203,351
Q
GWAS1144567_H
ovarian carcinoma QTL GWAS1144567 (human)
IAGP
rs1366161
3.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 5:5,174,755...5,174,756
Q
GWAS1144612_H
ovarian carcinoma QTL GWAS1144612 (human)
IAGP
rs151055883
2.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 5:143,894,315...143,894,316
Q
GWAS1144613_H
ovarian carcinoma QTL GWAS1144613 (human)
IAGP
rs77663385
9.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 6:44,327,218...44,327,219
Q
GWAS1144614_H
ovarian carcinoma QTL GWAS1144614 (human)
IAGP
rs7740903
5.0E-7
GWAS_CATALOG
PMID:31488892
NCBI chr 6:146,677,054...146,677,055
Q
GWAS1144615_H
ovarian carcinoma QTL GWAS1144615 (human)
IAGP
rs76926936
9.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 7:89,698,682...89,698,683
Q
GWAS1144616_H
ovarian carcinoma QTL GWAS1144616 (human)
IAGP
rs73494486
7.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 9:98,579,569...98,579,570
Q
GWAS1144617_H
ovarian carcinoma QTL GWAS1144617 (human)
IAGP
rs77336990
2.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr10:48,270,719...48,270,720
Q
GWAS1144618_H
ovarian carcinoma QTL GWAS1144618 (human)
IAGP
rs9989364
9.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr16:63,960,276...63,960,277
Q
GWAS1144619_H
ovarian carcinoma QTL GWAS1144619 (human)
IAGP
rs141803457
3.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr16:68,366,522...68,366,523
Q
GWAS1144620_H
ovarian carcinoma QTL GWAS1144620 (human)
IAGP
rs137866923
8.0E-7
GWAS_CATALOG
PMID:31488892
NCBI chr16:68,497,433...68,497,434
Q
GWAS1144621_H
ovarian carcinoma QTL GWAS1144621 (human)
IAGP
rs139505845
6.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr17:57,289,728...57,289,729
Q
GWAS1144658_H
ovarian carcinoma QTL GWAS1144658 (human)
IAGP
rs138807553
2.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr18:33,625,004...33,625,005
Q
GWAS1144659_H
ovarian carcinoma QTL GWAS1144659 (human)
IAGP
rs78286182
1.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr18:75,988,278...75,988,279
Q
GWAS1146472_H
ovarian carcinoma QTL GWAS1146472 (human)
IAGP
rs484686
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 1:172,183,062...172,183,063
Q
GWAS1146473_H
ovarian carcinoma QTL GWAS1146473 (human)
IAGP
rs537364753
6.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 2:184,453,308...184,453,309
Q
GWAS1146474_H
ovarian carcinoma QTL GWAS1146474 (human)
IAGP
rs75693602
7.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 2:205,631,096...205,631,097
Q
GWAS1146475_H
ovarian carcinoma QTL GWAS1146475 (human)
IAGP
rs150007914
7.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 3:171,410,134...171,410,135
Q
GWAS1146476_H
ovarian carcinoma QTL GWAS1146476 (human)
IAGP
rs7671115
6.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 4:164,203,350...164,203,351
Q
GWAS1146477_H
ovarian carcinoma QTL GWAS1146477 (human)
IAGP
rs57490377
9.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 4:185,621,753...185,621,754
Q
GWAS1146478_H
ovarian carcinoma QTL GWAS1146478 (human)
IAGP
rs1366161
6.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 5:5,174,755...5,174,756
Q
GWAS1146479_H
ovarian carcinoma QTL GWAS1146479 (human)
IAGP
rs151055883
6.0E-7
GWAS_CATALOG
PMID:31488892
NCBI chr 5:143,894,315...143,894,316
Q
GWAS1146480_H
ovarian carcinoma QTL GWAS1146480 (human)
IAGP
rs77663385
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 6:44,327,218...44,327,219
Q
GWAS1146481_H
ovarian carcinoma QTL GWAS1146481 (human)
IAGP
rs7740903
4.0E-7
GWAS_CATALOG
PMID:31488892
NCBI chr 6:146,677,054...146,677,055
Q
GWAS1146482_H
ovarian carcinoma QTL GWAS1146482 (human)
IAGP
rs76926936
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 7:89,698,682...89,698,683
Q
GWAS1146483_H
ovarian carcinoma QTL GWAS1146483 (human)
IAGP
rs147476757
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 9:126,011,262...126,011,263
Q
GWAS1146515_H
ovarian carcinoma QTL GWAS1146515 (human)
IAGP
rs201368489
4.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr14:64,414,689...64,414,690
Q
GWAS1146516_H
ovarian carcinoma QTL GWAS1146516 (human)
IAGP
rs141803457
1.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr16:68,366,522...68,366,523
Q
GWAS1146517_H
ovarian carcinoma QTL GWAS1146517 (human)
IAGP
rs137866923
3.0E-7
GWAS_CATALOG
PMID:31488892
NCBI chr16:68,497,433...68,497,434
Q
GWAS1146518_H
ovarian carcinoma QTL GWAS1146518 (human)
IAGP
rs572011593
4.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr17:27,694,464...27,694,465
Q
GWAS1146519_H
ovarian carcinoma QTL GWAS1146519 (human)
IAGP
rs139505845
1.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr17:57,289,728...57,289,729
Q
GWAS1146520_H
ovarian carcinoma QTL GWAS1146520 (human)
IAGP
rs146540010
9.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr17:69,216,249...69,216,250
Q
GWAS1161219_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161219 (human)
IAGP
rs77548871
5.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr 1:155,016,057...155,016,058
Q
GWAS1161220_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161220 (human)
IAGP
rs17041869
2.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr 2:111,138,666...111,138,667
Q
GWAS1161221_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161221 (human)
IAGP
rs739704
3.0E-14
GWAS_CATALOG
PMID:27432226
NCBI chr 7:27,950,149...27,950,150
Q
GWAS1161222_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161222 (human)
IAGP
rs720475
7.0E-12
GWAS_CATALOG
PMID:27432226
NCBI chr 7:144,377,836...144,377,837
Q
GWAS1161242_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161242 (human)
IAGP
rs7937840
2.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr11:62,126,500...62,126,501
Q
GWAS1161243_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161243 (human)
IAGP
rs72932523
1.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr11:69,138,652...69,138,653
Q
GWAS1161244_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161244 (human)
IAGP
rs2277509
9.0E-12
GWAS_CATALOG
PMID:27432226
NCBI chr14:91,283,251...91,283,252
Q
GWAS1161245_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161245 (human)
IAGP
rs2628317
4.0E-16
GWAS_CATALOG
PMID:27432226
NCBI chr17:55,135,212...55,135,213
Q
GWAS1161261_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1161261 (human)
IAGP
rs1469713
1.0E-10
GWAS_CATALOG
PMID:27432226
NCBI chr19:19,417,997...19,417,998
Q
GWAS1164825_H
lung carcinoma QTL GWAS1164825 (human)
IAGP
rs56404467
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,265,853...32,265,854
Q
GWAS1201787_H
ovarian carcinoma QTL GWAS1201787 (human)
IAGP
rs12061931
6.0E-8
GWAS_CATALOG
PMID:32887889
NCBI chr 1:3,779,792...3,779,793
Q
GWAS1208474_H
ovarian carcinoma QTL GWAS1208474 (human)
IAGP
rs185345278
5.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 1:93,933,038...93,933,039
Q
GWAS1208475_H
ovarian carcinoma QTL GWAS1208475 (human)
IAGP
rs188625872
2.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 1:156,114,696...156,114,697
Q
GWAS1208476_H
ovarian carcinoma QTL GWAS1208476 (human)
IAGP
rs12117623
1.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 1:172,072,640...172,072,641
Q
GWAS1208477_H
ovarian carcinoma QTL GWAS1208477 (human)
IAGP
rs17027263
2.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 2:86,459,965...86,459,966
Q
GWAS1208478_H
ovarian carcinoma QTL GWAS1208478 (human)
IAGP
rs12658731
9.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr 5:5,169,477...5,169,478
Q
GWAS1208479_H
ovarian carcinoma QTL GWAS1208479 (human)
IAGP
rs60982503
5.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 5:180,485,036...180,485,037
Q
GWAS1208648_H
ovarian carcinoma QTL GWAS1208648 (human)
IAGP
rs303051
6.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 6:10,403,963...10,403,964
Q
GWAS1208649_H
ovarian carcinoma QTL GWAS1208649 (human)
IAGP
rs56855829
2.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 6:35,464,877...35,464,878
Q
GWAS1208650_H
ovarian carcinoma QTL GWAS1208650 (human)
IAGP
rs73589840
7.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 6:146,688,554...146,688,555
Q
GWAS1208651_H
ovarian carcinoma QTL GWAS1208651 (human)
IAGP
rs10117922
7.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 9:87,680,655...87,680,656
Q
GWAS1208652_H
ovarian carcinoma QTL GWAS1208652 (human)
IAGP
rs2615880
8.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr10:115,937,294...115,937,295
Q
GWAS1208653_H
ovarian carcinoma QTL GWAS1208653 (human)
IAGP
rs58355101
9.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr12:70,257,391...70,257,392
Q
GWAS1208654_H
ovarian carcinoma QTL GWAS1208654 (human)
IAGP
rs1495352
3.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr12:70,359,064...70,359,065
Q
GWAS1208655_H
ovarian carcinoma QTL GWAS1208655 (human)
IAGP
rs75921351
8.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr16:54,596,587...54,596,588
Q
GWAS1208656_H
ovarian carcinoma QTL GWAS1208656 (human)
IAGP
rs145065165
2.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr16:55,347,327...55,347,328
Q
GWAS1208657_H
ovarian carcinoma QTL GWAS1208657 (human)
IAGP
rs11870446
3.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr17:5,857,509...5,857,510
Q
GWAS1209033_H
ovarian carcinoma QTL GWAS1209033 (human)
IAGP
rs12151036
5.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr19:58,202,868...58,202,869
Q
GWAS1209034_H
ovarian carcinoma QTL GWAS1209034 (human)
IAGP
rs1884920
8.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr20:56,648,010...56,648,011
Q
GWAS1209035_H
ovarian carcinoma QTL GWAS1209035 (human)
IAGP
rs137672
1.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr22:39,341,089...39,341,090
Q
GWAS1233327_H
neuroimaging measurement QTL GWAS1233327 (human)
IAGP
rs550057
2.0E-14
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,271,182...133,271,183
Q
GWAS1314983_H
ovarian carcinoma QTL GWAS1314983 (human)
IAGP
rs115128033
9.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 7:57,372,353...57,372,354
Q
GWAS1314984_H
ovarian carcinoma QTL GWAS1314984 (human)
IAGP
rs150698072
4.0E-8
GWAS_CATALOG
PMID:34290314
NCBI chr 7:122,011,697...122,011,698
Q
GWAS1314985_H
ovarian carcinoma QTL GWAS1314985 (human)
IAGP
rs4726091
3.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 7:151,775,905...151,775,906
Q
GWAS1314986_H
ovarian carcinoma QTL GWAS1314986 (human)
IAGP
rs182634476
8.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 8:144,437,000...144,437,001
Q
GWAS1314987_H
ovarian carcinoma QTL GWAS1314987 (human)
IAGP
rs181962423
8.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 9:34,972,355...34,972,356
Q
GWAS1314988_H
ovarian carcinoma QTL GWAS1314988 (human)
IAGP
rs141131642
5.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr11:10,778,732...10,778,733
Q
GWAS1314989_H
ovarian carcinoma QTL GWAS1314989 (human)
IAGP
rs67812265
6.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr11:57,776,189...57,776,190
Q
GWAS1315182_H
ovarian carcinoma QTL GWAS1315182 (human)
IAGP
rs201166499
8.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr17:41,734,613...41,734,614
Q
GWAS1321449_H
ovarian carcinoma QTL GWAS1321449 (human)
IAGP
rs113446565
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr X:3,776,745...3,776,746
Q
GWAS1321633_H
ovarian carcinoma QTL GWAS1321633 (human)
IAGP
rs1164587
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr13:96,391,464...96,391,465
Q
GWAS1321634_H
ovarian carcinoma QTL GWAS1321634 (human)
IAGP
rs11659469
5.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr18:49,657,424...49,657,425
Q
GWAS1321635_H
ovarian carcinoma QTL GWAS1321635 (human)
IAGP
rs11684751
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:150,393,944...150,393,945
Q
GWAS1321636_H
ovarian carcinoma QTL GWAS1321636 (human)
IAGP
rs11724690
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:185,843,593...185,843,594
Q
GWAS1321637_H
ovarian carcinoma QTL GWAS1321637 (human)
IAGP
rs11973028
1.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:27,853,217...27,853,218
Q
GWAS1321638_H
ovarian carcinoma QTL GWAS1321638 (human)
IAGP
rs11980115
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:133,141,119...133,141,120
Q
GWAS1321639_H
ovarian carcinoma QTL GWAS1321639 (human)
IAGP
rs12603880
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr17:57,668,632...57,668,633
Q
GWAS1321640_H
ovarian carcinoma QTL GWAS1321640 (human)
IAGP
rs135573
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr22:46,131,359...46,131,360
Q
GWAS1321641_H
ovarian carcinoma QTL GWAS1321641 (human)
IAGP
rs1413017
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr20:12,691,366...12,691,367
Q
GWAS1321642_H
ovarian carcinoma QTL GWAS1321642 (human)
IAGP
rs144199732
7.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr X:43,022,624...43,022,625
Q
GWAS1321643_H
ovarian carcinoma QTL GWAS1321643 (human)
IAGP
rs146343288
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:17,689,625...17,689,626
Q
GWAS1321644_H
ovarian carcinoma QTL GWAS1321644 (human)
IAGP
rs146917711
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:112,609,781...112,609,782
Q
GWAS1321645_H
ovarian carcinoma QTL GWAS1321645 (human)
IAGP
rs11426758
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr17:4,274,199...4,274,200
Q
GWAS1321827_H
ovarian carcinoma QTL GWAS1321827 (human)
IAGP
rs12568748
9.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 1:221,657,667...221,657,668
Q
GWAS1321828_H
ovarian carcinoma QTL GWAS1321828 (human)
IAGP
rs12623068
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:7,182,908...7,182,909
Q
GWAS1321829_H
ovarian carcinoma QTL GWAS1321829 (human)
IAGP
rs10009522
9.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:153,242,242...153,242,243
Q
GWAS1321830_H
ovarian carcinoma QTL GWAS1321830 (human)
IAGP
rs10260419
1.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr 7:11,524,758...11,524,759
Q
GWAS1321831_H
ovarian carcinoma QTL GWAS1321831 (human)
IAGP
rs10400919
6.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr15:27,084,081...27,084,082
Q
GWAS1321832_H
ovarian carcinoma QTL GWAS1321832 (human)
IAGP
rs10627733
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 1:21,141,377...21,141,378
Q
GWAS1321833_H
ovarian carcinoma QTL GWAS1321833 (human)
IAGP
rs111478044
9.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr21:21,308,068...21,308,069
Q
GWAS1321834_H
ovarian carcinoma QTL GWAS1321834 (human)
IAGP
rs11150225
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr16:79,856,062...79,856,063
Q
GWAS1321835_H
ovarian carcinoma QTL GWAS1321835 (human)
IAGP
rs111970895
3.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr 5:102,301,953...102,301,957
Q
GWAS1325893_H
ovarian carcinoma QTL GWAS1325893 (human)
IAGP
rs72745575
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 9:81,548,365...81,548,366
Q
GWAS1326123_H
ovarian carcinoma QTL GWAS1326123 (human)
IAGP
rs7644028
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:176,972,255...176,972,256
Q
GWAS1326124_H
ovarian carcinoma QTL GWAS1326124 (human)
IAGP
rs78649302
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr13:113,481,059...113,481,060
Q
GWAS1326125_H
ovarian carcinoma QTL GWAS1326125 (human)
IAGP
rs78950910
9.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr13:29,266,071...29,266,072
Q
GWAS1326126_H
ovarian carcinoma QTL GWAS1326126 (human)
IAGP
rs79925169
5.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 9:89,469,330...89,469,331
Q
GWAS1326127_H
ovarian carcinoma QTL GWAS1326127 (human)
IAGP
rs80119973
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 8:13,963,095...13,963,096
Q
GWAS1326128_H
ovarian carcinoma QTL GWAS1326128 (human)
IAGP
rs8069681
1.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr17:5,064,847...5,064,848
Q
GWAS1326129_H
ovarian carcinoma QTL GWAS1326129 (human)
IAGP
rs870274
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr10:122,120,548...122,120,549
Q
GWAS1326130_H
ovarian carcinoma QTL GWAS1326130 (human)
IAGP
rs9316411
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr13:48,747,718...48,747,719
Q
GWAS1326131_H
ovarian carcinoma QTL GWAS1326131 (human)
IAGP
rs9791676
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:42,053,156...42,053,157
Q
GWAS1326132_H
ovarian carcinoma QTL GWAS1326132 (human)
IAGP
rs151224156
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:57,784,687...57,784,688
Q
GWAS1326133_H
ovarian carcinoma QTL GWAS1326133 (human)
IAGP
rs1728807
9.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:11,007,643...11,007,644
Q
GWAS1326134_H
ovarian carcinoma QTL GWAS1326134 (human)
IAGP
rs17808848
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 5:175,210,799...175,210,800
Q
GWAS1326135_H
ovarian carcinoma QTL GWAS1326135 (human)
IAGP
rs1791890
3.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr11:116,120,763...116,120,764
Q
GWAS1326365_H
ovarian carcinoma QTL GWAS1326365 (human)
IAGP
rs1800351
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr13:23,250,644...23,250,645
Q
GWAS1326366_H
ovarian carcinoma QTL GWAS1326366 (human)
IAGP
rs185335029
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:26,787,883...26,787,884
Q
GWAS1326367_H
ovarian carcinoma QTL GWAS1326367 (human)
IAGP
rs2371271
6.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:211,451,963...211,451,964
Q
GWAS1326368_H
ovarian carcinoma QTL GWAS1326368 (human)
IAGP
rs243172
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr14:89,546,219...89,546,220
Q
GWAS1326369_H
ovarian carcinoma QTL GWAS1326369 (human)
IAGP
rs2829235
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr21:24,659,554...24,659,555
Q
GWAS1326370_H
ovarian carcinoma QTL GWAS1326370 (human)
IAGP
rs28734075
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:3,824,215...3,824,216
Q
GWAS1326371_H
ovarian carcinoma QTL GWAS1326371 (human)
IAGP
rs34097398
4.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr X:33,452,414...33,452,415
Q
GWAS1326372_H
ovarian carcinoma QTL GWAS1326372 (human)
IAGP
rs34350340
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr X:119,837,615...119,837,616
Q
GWAS1326373_H
ovarian carcinoma QTL GWAS1326373 (human)
IAGP
rs34357515
1.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr19:3,197,621...3,197,622
Q
GWAS1326374_H
ovarian carcinoma QTL GWAS1326374 (human)
IAGP
rs35941888
5.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr22:28,343,529...28,343,530
Q
GWAS1326623_H
ovarian carcinoma QTL GWAS1326623 (human)
IAGP
rs40409
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:61,992,237...61,992,238
Q
GWAS1326862_H
ovarian carcinoma QTL GWAS1326862 (human)
IAGP
rs56236040
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:51,423,896...51,423,897
Q
GWAS1326863_H
ovarian carcinoma QTL GWAS1326863 (human)
IAGP
rs57960590
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:151,590,844...151,590,845
Q
GWAS1326864_H
ovarian carcinoma QTL GWAS1326864 (human)
IAGP
rs58142303
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 5:90,981,864...90,981,865
Q
GWAS1326865_H
ovarian carcinoma QTL GWAS1326865 (human)
IAGP
rs59923016
1.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr16:49,765,544...49,765,545
Q
GWAS1326866_H
ovarian carcinoma QTL GWAS1326866 (human)
IAGP
rs60930737
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr10:25,607,085...25,607,092
Q
GWAS1326867_H
ovarian carcinoma QTL GWAS1326867 (human)
IAGP
rs4362851
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:167,363,437...167,363,438
Q
GWAS1326868_H
ovarian carcinoma QTL GWAS1326868 (human)
IAGP
rs4709698
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:163,301,732...163,301,733
Q
GWAS1326869_H
ovarian carcinoma QTL GWAS1326869 (human)
IAGP
rs4918665
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr10:111,552,672...111,552,673
Q
GWAS1326870_H
ovarian carcinoma QTL GWAS1326870 (human)
IAGP
rs6461701
5.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:2,916,633...2,916,634
Q
GWAS1326871_H
ovarian carcinoma QTL GWAS1326871 (human)
IAGP
rs67729017
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 8:50,701,586...50,701,587
Q
GWAS1326872_H
ovarian carcinoma QTL GWAS1326872 (human)
IAGP
rs70959845
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:60,572,848...60,572,849
Q
GWAS1326873_H
ovarian carcinoma QTL GWAS1326873 (human)
IAGP
rs7172033
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr15:59,949,310...59,949,311
Q
GWAS1326874_H
ovarian carcinoma QTL GWAS1326874 (human)
IAGP
rs72492309
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:32,541,977...32,541,978
Q
GWAS1327355_H
ovarian carcinoma QTL GWAS1327355 (human)
IAGP
rs987254
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:169,266,197...169,266,198
Q
GWAS1339947_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339947 (human)
IAGP
rs12243396
5.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr10:86,171,880...86,171,881
Q
GWAS1339948_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339948 (human)
IAGP
rs35709804
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr10:133,024,074...133,024,075
Q
GWAS1339949_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339949 (human)
IAGP
rs5752640
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr22:27,807,762...27,807,763
Q
GWAS1339950_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1339950 (human)
IAGP
rs735252
5.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr22:47,124,913...47,124,914
Q
GWAS1339951_H
progression free survival, ovarian carcinoma QTL GWAS1339951 (human)
IAGP
rs67654717
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:15,170,390...15,170,391
Q
GWAS1339985_H
progression free survival, ovarian carcinoma QTL GWAS1339985 (human)
IAGP
rs35241450
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr22:29,117,567...29,117,568
Q
GWAS1340144_H
progression free survival, ovarian carcinoma QTL GWAS1340144 (human)
IAGP
rs2125653
8.0E-7
GWAS_CATALOG
PMID:34162658
NCBI chr 4:18,116,414...18,116,415
Q
GWAS1340145_H
progression free survival, ovarian carcinoma QTL GWAS1340145 (human)
IAGP
rs74760478
5.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 6:10,841,524...10,841,525
Q
GWAS1340146_H
progression free survival, ovarian carcinoma QTL GWAS1340146 (human)
IAGP
rs139827288
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:37,228,787...37,228,788
Q
GWAS1340147_H
progression free survival, ovarian carcinoma QTL GWAS1340147 (human)
IAGP
rs2017441
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 9:84,923,681...84,923,682
Q
GWAS1340148_H
progression free survival, ovarian carcinoma QTL GWAS1340148 (human)
IAGP
rs78007224
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr14:36,881,274...36,881,275
Q
GWAS1340149_H
progression free survival, ovarian carcinoma QTL GWAS1340149 (human)
IAGP
rs58244431
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr14:58,210,731...58,210,732
Q
GWAS1340150_H
progression free survival, ovarian carcinoma QTL GWAS1340150 (human)
IAGP
rs2847516
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr18:36,339,642...36,339,643
Q
GWAS1340151_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340151 (human)
IAGP
rs55950243
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 1:29,843,121...29,843,122
Q
GWAS1340152_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340152 (human)
IAGP
rs147138325
4.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 1:65,863,804...65,863,805
Q
GWAS1340153_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340153 (human)
IAGP
rs58116956
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 1:81,655,410...81,655,411
Q
GWAS1340318_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340318 (human)
IAGP
rs2070707
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:79,121,070...79,121,071
Q
GWAS1340319_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340319 (human)
IAGP
rs17018999
3.0E-7
GWAS_CATALOG
PMID:34162658
NCBI chr 2:80,340,409...80,340,410
Q
GWAS1340320_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340320 (human)
IAGP
rs115676291
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:124,177,399...124,177,400
Q
GWAS1340321_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340321 (human)
IAGP
rs66530326
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:124,314,987...124,314,988
Q
GWAS1340322_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340322 (human)
IAGP
rs1082422
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:76,808,163...76,808,164
Q
GWAS1340323_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340323 (human)
IAGP
rs113526453
5.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:97,419,623...97,419,624
Q
GWAS1340324_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340324 (human)
IAGP
rs11096798
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 4:36,092,509...36,092,510
Q
GWAS1340325_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340325 (human)
IAGP
rs142157655
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 4:113,992,588...113,992,589
Q
GWAS1340326_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340326 (human)
IAGP
rs59152766
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 5:59,531,580...59,531,581
Q
GWAS1340327_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340327 (human)
IAGP
rs35893266
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 5:76,450,735...76,450,736
Q
GWAS1340328_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340328 (human)
IAGP
rs144087161
1.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:114,572,597...114,572,598
Q
GWAS1340329_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340329 (human)
IAGP
rs139156430
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:155,319,558...155,319,559
Q
GWAS1340330_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340330 (human)
IAGP
rs6985728
1.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 8:19,794,927...19,794,928
Q
GWAS1340493_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340493 (human)
IAGP
rs72718849
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 8:121,577,705...121,577,706
Q
GWAS1340494_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340494 (human)
IAGP
rs11141915
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 9:87,620,879...87,620,880
Q
GWAS1340495_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340495 (human)
IAGP
rs10752194
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr10:6,072,330...6,072,331
Q
GWAS1343674_H
ovarian carcinoma QTL GWAS1343674 (human)
IAGP
rs146976708
4.0E-7
GWAS_CATALOG
PMID:34290314
NCBI chr 1:48,298,840...48,298,841
Q
GWAS1343675_H
ovarian carcinoma QTL GWAS1343675 (human)
IAGP
rs115092288
1.0E-7
GWAS_CATALOG
PMID:34290314
NCBI chr 1:114,673,738...114,673,739
Q
GWAS1343676_H
ovarian carcinoma QTL GWAS1343676 (human)
IAGP
rs80104686
2.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 3:45,158,636...45,158,637
Q
GWAS1343677_H
ovarian carcinoma QTL GWAS1343677 (human)
IAGP
rs80192073
1.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 4:40,121,779...40,121,780
Q
GWAS1343678_H
ovarian carcinoma QTL GWAS1343678 (human)
IAGP
rs74375290
6.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 6:31,129,248...31,129,249
Q
GWAS1343679_H
ovarian carcinoma QTL GWAS1343679 (human)
IAGP
rs137852915
4.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr 6:145,686,276...145,686,277
Q
GWAS1353931_H
family history of lung cancer QTL GWAS1353931 (human)
IAGP
rs11571833
8.0E-12
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,398,489...32,398,490
Q
GWAS1376382_H
overall survival, ovarian carcinoma QTL GWAS1376382 (human)
IAGP
rs7631664
9.0E-10
GWAS_CATALOG
PMID:34930913
NCBI chr 3:4,709,568...4,709,569
Q
GWAS1401509_H
breast cancer, ovarian carcinoma QTL GWAS1401509 (human)
IAGP
rs3814113
2.0E-43
GWAS_CATALOG
PMID:36819030
NCBI chr 9:16,915,023...16,915,024
Q
GWAS1402492_H
breast cancer, ovarian carcinoma QTL GWAS1402492 (human)
IAGP
rs1219648
4E-254
GWAS_CATALOG
PMID:36819030
NCBI chr10:121,586,676...121,586,677
Q
GWAS1402493_H
breast cancer, ovarian carcinoma QTL GWAS1402493 (human)
IAGP
rs7098100
4.0E-27
GWAS_CATALOG
PMID:36819030
NCBI chr10:21,545,607...21,545,608
Q
GWAS1402494_H
breast cancer, ovarian carcinoma QTL GWAS1402494 (human)
IAGP
rs2277509
2.0E-11
GWAS_CATALOG
PMID:36819030
NCBI chr14:91,283,251...91,283,252
Q
GWAS1402495_H
breast cancer, ovarian carcinoma QTL GWAS1402495 (human)
IAGP
rs10498635
9.0E-13
GWAS_CATALOG
PMID:36819030
NCBI chr14:92,636,964...92,636,965
Q
GWAS1402496_H
breast cancer, ovarian carcinoma QTL GWAS1402496 (human)
IAGP
rs244353
1.0E-31
GWAS_CATALOG
PMID:36819030
NCBI chr17:55,117,408...55,117,409
Q
GWAS1402497_H
breast cancer, ovarian carcinoma QTL GWAS1402497 (human)
IAGP
rs4808616
2.0E-23
GWAS_CATALOG
PMID:36819030
NCBI chr19:17,292,224...17,292,225
Q
GWAS1402498_H
breast cancer, ovarian carcinoma QTL GWAS1402498 (human)
IAGP
rs2916074
2.0E-11
GWAS_CATALOG
PMID:36819030
NCBI chr19:19,419,461...19,419,462
Q
GWAS1402499_H
breast cancer, ovarian carcinoma QTL GWAS1402499 (human)
IAGP
rs3769823
1.0E-16
GWAS_CATALOG
PMID:36819030
NCBI chr 2:201,258,272...201,258,273
Q
GWAS1402500_H
breast cancer, ovarian carcinoma QTL GWAS1402500 (human)
IAGP
rs1474961
2.0E-15
GWAS_CATALOG
PMID:36819030
NCBI chr22:28,643,439...28,643,440
Q
GWAS1402501_H
breast cancer, ovarian carcinoma QTL GWAS1402501 (human)
IAGP
rs9878602
4.0E-8
GWAS_CATALOG
PMID:36819030
NCBI chr 3:71,486,187...71,486,188
Q
GWAS1402502_H
breast cancer, ovarian carcinoma QTL GWAS1402502 (human)
IAGP
rs6826366
3.0E-28
GWAS_CATALOG
PMID:36819030
NCBI chr 4:174,924,959...174,924,960
Q
GWAS1402503_H
breast cancer, ovarian carcinoma QTL GWAS1402503 (human)
IAGP
rs10069690
5.0E-23
GWAS_CATALOG
PMID:36819030
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1402504_H
breast cancer, ovarian carcinoma QTL GWAS1402504 (human)
IAGP
rs381551
2.0E-12
GWAS_CATALOG
PMID:36819030
NCBI chr 6:13,716,491...13,716,492
Q
GWAS1402505_H
breast cancer, ovarian carcinoma QTL GWAS1402505 (human)
IAGP
rs851980
9.0E-20
GWAS_CATALOG
PMID:36819030
NCBI chr 6:151,706,820...151,706,821
Q
GWAS1402506_H
breast cancer, ovarian carcinoma QTL GWAS1402506 (human)
IAGP
rs720475
9.0E-11
GWAS_CATALOG
PMID:36819030
NCBI chr 7:144,377,836...144,377,837
Q
GWAS1402507_H
breast cancer, ovarian carcinoma QTL GWAS1402507 (human)
IAGP
rs7017073
4.0E-14
GWAS_CATALOG
PMID:36819030
NCBI chr 8:128,192,016...128,192,017
Q
GWAS1402732_H
breast cancer, ovarian carcinoma QTL GWAS1402732 (human)
IAGP
rs2941478
5.0E-8
GWAS_CATALOG
PMID:36819030
NCBI chr 8:75,564,502...75,564,503
Q
GWAS1402733_H
breast cancer, ovarian carcinoma QTL GWAS1402733 (human)
IAGP
rs630965
1.0E-63
GWAS_CATALOG
PMID:36819030
NCBI chr 9:108,123,199...108,123,200
Q
GWAS1404232_H
breast cancer, ovarian carcinoma QTL GWAS1404232 (human)
IAGP
rs495828
7.0E-11
GWAS_CATALOG
PMID:36819030
NCBI chr 9:133,279,294...133,279,295
Q
GWAS1424873_H
ovarian carcinoma, COVID-19 QTL GWAS1424873 (human)
IAGP
rs145526382
7.0E-9
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,246,236...133,246,237
Q
GWAS1424874_H
ovarian carcinoma, COVID-19 QTL GWAS1424874 (human)
IAGP
rs554833
1E-88
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,271,745...133,271,746
Q
GWAS1424875_H
ovarian carcinoma, COVID-19 QTL GWAS1424875 (human)
IAGP
rs56343119
1.0E-22
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,370,796...133,370,797
Q
GWAS1424876_H
ovarian carcinoma, COVID-19 QTL GWAS1424876 (human)
IAGP
rs11244061
1.0E-9
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,278,537...133,278,538
Q
GWAS1424877_H
ovarian carcinoma, COVID-19 QTL GWAS1424877 (human)
IAGP
rs63750417
6.0E-16
GWAS_CATALOG
PMID:37636041
NCBI chr17:45,983,409...45,983,410
Q
GWAS1425013_H
ovarian carcinoma, COVID-19 QTL GWAS1425013 (human)
IAGP
rs657152
6.0E-25
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,263,862...133,263,863
Q
GWAS1425014_H
ovarian carcinoma, COVID-19 QTL GWAS1425014 (human)
IAGP
rs70602
6.0E-14
GWAS_CATALOG
PMID:37636041
NCBI chr17:46,782,349...46,782,350
Q
GWAS1425015_H
ovarian carcinoma, COVID-19 QTL GWAS1425015 (human)
IAGP
rs71238846
2.0E-13
GWAS_CATALOG
PMID:37636041
NCBI chr17:45,475,171...45,475,172
Q
GWAS1425016_H
ovarian carcinoma, COVID-19 QTL GWAS1425016 (human)
IAGP
rs199512
3.0E-15
GWAS_CATALOG
PMID:37636041
NCBI chr17:46,779,986...46,779,987
Q
GWAS1425017_H
ovarian carcinoma, COVID-19 QTL GWAS1425017 (human)
IAGP
rs2532276
4.0E-13
GWAS_CATALOG
PMID:37636041
NCBI chr17:46,169,258...46,169,259
Q
GWAS1428856_H
ovarian carcinoma QTL GWAS1428856 (human)
IAGP
rs2853669
5.0E-8
GWAS_CATALOG
PMID:38723632
NCBI chr 5:1,295,234...1,295,235
Q
GWAS1428857_H
ovarian carcinoma QTL GWAS1428857 (human)
IAGP
rs336126
6.0E-11
GWAS_CATALOG
PMID:38723632
NCBI chr 5:55,180,728...55,180,729
Q
GWAS1429000_H
ovarian carcinoma QTL GWAS1429000 (human)
IAGP
rs2070368
1.0E-8
GWAS_CATALOG
PMID:38723632
NCBI chr21:34,708,100...34,708,101
Q
GWAS1456967_H
granulocyte count QTL GWAS1456967 (human)
IAGP
rs7679673
1.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 4:105,140,377...105,140,378
Q
GWAS1457463_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457463 (human)
IAGP
rs186507655
5.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 1:1,351,675...1,351,676
Q
GWAS1457536_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457536 (human)
IAGP
rs1862626
4.0E-12
GWAS_CATALOG
PMID:27197191
NCBI chr 5:56,737,113...56,737,114
Q
GWAS1457537_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457537 (human)
IAGP
rs147680653
1.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457538_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457538 (human)
IAGP
rs115707823
5.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457539_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457539 (human)
IAGP
rs115392158
3.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457540_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457540 (human)
IAGP
rs147527678
6.0E-8
GWAS_CATALOG
PMID:27197191
Q
GWAS1457604_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457604 (human)
IAGP
rs1011970
5.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 9:22,062,135...22,062,136
Q
GWAS1457605_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457605 (human)
IAGP
rs148883465
3.0E-8
GWAS_CATALOG
PMID:27197191
NCBI chr11:103,813,371...103,813,372
Q
GWAS1457606_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457606 (human)
IAGP
rs11168936
9.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr12:49,251,457...49,251,458
Q
GWAS1457607_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma QTL GWAS1457607 (human)
IAGP
rs3184504
1.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,446,804...111,446,805
Q
GWAS1457608_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457608 (human)
IAGP
rs1057941
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:155,216,951...155,216,952
Q
GWAS1457609_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457609 (human)
IAGP
rs2974935
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:155,212,052...155,212,053
Q
GWAS1457676_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457676 (human)
IAGP
rs115707823
2.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457677_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457677 (human)
IAGP
rs115392158
9.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457678_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457678 (human)
IAGP
rs147527678
5.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457679_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457679 (human)
IAGP
rs12349081
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 9:21,951,903...21,951,904
Q
GWAS1457680_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457680 (human)
IAGP
rs1011970
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 9:22,062,135...22,062,136
Q
GWAS1457681_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457681 (human)
IAGP
rs3184504
2.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,446,804...111,446,805
Q
GWAS1457776_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457776 (human)
IAGP
rs141752671
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr11:103,745,837...103,745,838
Q
GWAS1457777_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457777 (human)
IAGP
rs11065979
5.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,621,753...111,621,754
Q
GWAS1467225_H
ovarian carcinoma QTL GWAS1467225 (human)
IAGP
rs10088218
3.0E-12
GWAS_CATALOG
PMID:23535730
NCBI chr 8:128,531,703...128,531,704
Q
GWAS1467226_H
ovarian carcinoma QTL GWAS1467226 (human)
IAGP
rs10088218
1.0E-17
GWAS_CATALOG
PMID:23535730
NCBI chr 8:128,531,703...128,531,704
Q
GWAS1467227_H
ovarian carcinoma QTL GWAS1467227 (human)
IAGP
rs2072590
5.0E-11
GWAS_CATALOG
PMID:23535730
NCBI chr 2:176,177,905...176,177,906
Q
GWAS1467228_H
ovarian carcinoma QTL GWAS1467228 (human)
IAGP
rs2072590
3.0E-10
GWAS_CATALOG
PMID:23535730
NCBI chr 2:176,177,905...176,177,906
Q
GWAS1467229_H
ovarian carcinoma QTL GWAS1467229 (human)
IAGP
rs7651446
2.0E-29
GWAS_CATALOG
PMID:23535730
NCBI chr 3:156,689,208...156,689,209
Q
GWAS1467230_H
ovarian carcinoma QTL GWAS1467230 (human)
IAGP
rs7651446
2.0E-34
GWAS_CATALOG
PMID:23535730
NCBI chr 3:156,689,208...156,689,209
Q
GWAS1470463_H
ovarian carcinoma QTL GWAS1470463 (human)
IAGP
rs2665390
3.0E-7
GWAS_CATALOG
PMID:20852632
NCBI chr 3:156,679,960...156,679,961
Q
GWAS1470464_H
ovarian carcinoma QTL GWAS1470464 (human)
IAGP
rs7521902
5.0E-6
GWAS_CATALOG
PMID:20852632
NCBI chr 1:22,164,231...22,164,232
Q
GWAS1470465_H
ovarian carcinoma QTL GWAS1470465 (human)
IAGP
rs2072590
5.0E-14
GWAS_CATALOG
PMID:20852632
NCBI chr 2:176,177,905...176,177,906
Q
GWAS1470466_H
ovarian carcinoma QTL GWAS1470466 (human)
IAGP
rs10088218
3.0E-9
GWAS_CATALOG
PMID:20852632
NCBI chr 8:128,531,703...128,531,704
Q
GWAS1470523_H
ovarian carcinoma QTL GWAS1470523 (human)
IAGP
rs183211
3.0E-8
GWAS_CATALOG
PMID:23544013
NCBI chr17:46,710,944...46,710,945
Q
GWAS1470524_H
ovarian carcinoma QTL GWAS1470524 (human)
IAGP
rs2665390
7.0E-6
GWAS_CATALOG
PMID:23544013
NCBI chr 3:156,679,960...156,679,961
Q
GWAS1470525_H
ovarian carcinoma QTL GWAS1470525 (human)
IAGP
rs4691139
3.0E-8
GWAS_CATALOG
PMID:23544013
NCBI chr 4:164,987,569...164,987,570
Q
GWAS1477252_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477252 (human)
IAGP
rs1763604
7.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr 1:16,013,277...16,013,278
Q
GWAS1477253_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477253 (human)
IAGP
rs13007211
1.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr 2:85,573,959...85,573,960
Q
GWAS1477254_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477254 (human)
IAGP
rs57251748
9.0E-12
GWAS_CATALOG
PMID:27432226
NCBI chr 4:105,137,028...105,137,030
Q
GWAS1477255_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477255 (human)
IAGP
rs17762342
2.0E-15
GWAS_CATALOG
PMID:27432226
NCBI chr 8:126,990,792...126,990,793
Q
GWAS1477256_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477256 (human)
IAGP
rs3802173
3.0E-11
GWAS_CATALOG
PMID:27432226
NCBI chr 8:128,187,668...128,187,669
Q
GWAS1477257_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477257 (human)
IAGP
rs9657608
1.0E-10
GWAS_CATALOG
PMID:27432226
NCBI chr 9:21,956,231...21,956,232
Q
GWAS1477258_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477258 (human)
IAGP
rs7898685
3.0E-10
GWAS_CATALOG
PMID:27432226
NCBI chr10:22,010,574...22,010,575
Q
GWAS1477259_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477259 (human)
IAGP
rs568110
5.0E-12
GWAS_CATALOG
PMID:27432226
NCBI chr10:113,390,512...113,390,513
Q
GWAS1477260_H
prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477260 (human)
IAGP
rs118151305
6.0E-9
GWAS_CATALOG
PMID:27432226
NCBI chr11:66,324,772...66,324,773
Q
GWAS1483232_H
ovarian carcinoma QTL GWAS1483232 (human)
IAGP
rs1400482
7.0E-26
GWAS_CATALOG
PMID:28346442
NCBI chr 8:128,529,685...128,529,686
Q
GWAS1483233_H
ovarian carcinoma QTL GWAS1483233 (human)
IAGP
rs144962376
4.0E-11
GWAS_CATALOG
PMID:28346442
Q
GWAS1483450_H
ovarian carcinoma QTL GWAS1483450 (human)
IAGP
rs62274041
3.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 3:156,717,851...156,717,852
Q
GWAS1483451_H
ovarian carcinoma QTL GWAS1483451 (human)
IAGP
rs62274041
2.0E-57
GWAS_CATALOG
PMID:28346442
NCBI chr 3:156,717,851...156,717,852
Q
GWAS1483452_H
ovarian carcinoma QTL GWAS1483452 (human)
IAGP
rs6755777
3.0E-15
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1483453_H
ovarian carcinoma QTL GWAS1483453 (human)
IAGP
rs711830
3.0E-15
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1483454_H
ovarian carcinoma QTL GWAS1483454 (human)
IAGP
rs2165109
2.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 2:111,061,081...111,061,082
Q
GWAS1483455_H
ovarian carcinoma QTL GWAS1483455 (human)
IAGP
rs9886651
2.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr 8:127,805,637...127,805,638
Q
GWAS1483456_H
ovarian carcinoma QTL GWAS1483456 (human)
IAGP
rs7953249
5.0E-10
GWAS_CATALOG
PMID:28346442
NCBI chr12:120,965,921...120,965,922
Q
GWAS1483457_H
ovarian carcinoma QTL GWAS1483457 (human)
IAGP
rs9870207
3.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 3:190,807,727...190,807,728
Q
GWAS1497353_H
ovarian carcinoma QTL GWAS1497353 (human)
IAGP
rs12031579
8.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr 1:119,307,920...119,307,921
Q
GWAS1497354_H
ovarian carcinoma QTL GWAS1497354 (human)
IAGP
rs6801612
8.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 3:186,920,430...186,920,431
Q
GWAS1497355_H
ovarian carcinoma QTL GWAS1497355 (human)
IAGP
rs147867139
8.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 5:139,712,729...139,712,730
Q
GWAS1497356_H
ovarian carcinoma QTL GWAS1497356 (human)
IAGP
rs4599655
8.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 6:96,284,381...96,284,382
Q
GWAS1497357_H
ovarian carcinoma QTL GWAS1497357 (human)
IAGP
rs181474944
6.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 7:47,770,503...47,770,504
Q
GWAS1497358_H
ovarian carcinoma QTL GWAS1497358 (human)
IAGP
rs10858374
1.0E-6
GWAS_CATALOG
PMID:30557369
NCBI chr 9:135,247,660...135,247,661
Q
GWAS1497359_H
ovarian carcinoma QTL GWAS1497359 (human)
IAGP
rs789336
1.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr12:70,028,700...70,028,701
Q
GWAS1497360_H
ovarian carcinoma QTL GWAS1497360 (human)
IAGP
rs7969255
8.0E-7
GWAS_CATALOG
PMID:30557369
NCBI chr12:70,148,026...70,148,027
Q
GWAS1504807_H
breast cancer, ovarian carcinoma QTL GWAS1504807 (human)
IAGP
rs2290202
4.0E-20
GWAS_CATALOG
PMID:36819030
NCBI chr15:90,969,037...90,969,038
Q
GWAS1504808_H
breast cancer, ovarian carcinoma QTL GWAS1504808 (human)
IAGP
rs35958868
5.0E-13
GWAS_CATALOG
PMID:36819030
NCBI chr17:30,909,727...30,909,728
Q
GWAS1504809_H
breast cancer, ovarian carcinoma QTL GWAS1504809 (human)
IAGP
rs4277389
1.0E-23
GWAS_CATALOG
PMID:36819030
NCBI chr17:45,818,287...45,818,288
Q
GWAS1504810_H
breast cancer, ovarian carcinoma QTL GWAS1504810 (human)
IAGP
rs1550623
3.0E-9
GWAS_CATALOG
PMID:36819030
NCBI chr 2:173,348,166...173,348,167
Q
GWAS1504811_H
breast cancer, ovarian carcinoma QTL GWAS1504811 (human)
IAGP
rs2822991
6.0E-10
GWAS_CATALOG
PMID:36819030
NCBI chr21:14,981,210...14,981,211
Q
GWAS1504812_H
breast cancer, ovarian carcinoma QTL GWAS1504812 (human)
IAGP
rs12233670
8.0E-12
GWAS_CATALOG
PMID:36819030
NCBI chr 4:38,785,595...38,785,596
Q
GWAS1505090_H
breast cancer, ovarian carcinoma QTL GWAS1505090 (human)
IAGP
rs4743687
5.0E-9
GWAS_CATALOG
PMID:36819030
NCBI chr 9:104,094,629...104,094,630
Q
GWAS1507403_H
ovarian carcinoma QTL GWAS1507403 (human)
IAGP
rs972834
7.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr X:23,276,803...23,276,804
Q
GWAS1507721_H
ovarian carcinoma QTL GWAS1507721 (human)
IAGP
rs79219469
3.0E-8
GWAS_CATALOG
PMID:31488892
NCBI chr16:54,553,941...54,553,942
Q
GWAS1507722_H
ovarian carcinoma QTL GWAS1507722 (human)
IAGP
rs567534295
3.0E-8
GWAS_CATALOG
PMID:31488892
NCBI chr17:43,048,090...43,048,091
Q
GWAS1507723_H
ovarian carcinoma QTL GWAS1507723 (human)
IAGP
rs143623984
9.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 1:101,301,117...101,301,118
Q
GWAS1507724_H
ovarian carcinoma QTL GWAS1507724 (human)
IAGP
rs12031579
1.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 1:119,307,920...119,307,921
Q
GWAS1507725_H
ovarian carcinoma QTL GWAS1507725 (human)
IAGP
rs13402729
1.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 2:226,482,173...226,482,174
Q
GWAS1507733_H
ovarian carcinoma QTL GWAS1507733 (human)
IAGP
rs7563767
2.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 2:242,012,658...242,012,659
Q
GWAS1507734_H
ovarian carcinoma QTL GWAS1507734 (human)
IAGP
rs146572601
5.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 3:70,110,053...70,110,054
Q
GWAS1507735_H
ovarian carcinoma QTL GWAS1507735 (human)
IAGP
rs191223340
3.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 3:70,224,942...70,224,943
Q
GWAS1507736_H
ovarian carcinoma QTL GWAS1507736 (human)
IAGP
rs148570926
3.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 5:139,690,696...139,690,697
Q
GWAS1507737_H
ovarian carcinoma QTL GWAS1507737 (human)
IAGP
rs148037216
2.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 8:48,645,458...48,645,459
Q
GWAS1507738_H
ovarian carcinoma QTL GWAS1507738 (human)
IAGP
rs78375425
3.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr13:39,329,007...39,329,008
Q
GWAS1507739_H
ovarian carcinoma QTL GWAS1507739 (human)
IAGP
rs141118132
8.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr13:52,517,465...52,517,466
Q
GWAS1508041_H
ovarian carcinoma QTL GWAS1508041 (human)
IAGP
rs79219469
2.0E-7
GWAS_CATALOG
PMID:31488892
NCBI chr16:54,553,941...54,553,942
Q
GWAS1508042_H
ovarian carcinoma QTL GWAS1508042 (human)
IAGP
rs567534295
5.0E-8
GWAS_CATALOG
PMID:31488892
NCBI chr17:43,048,090...43,048,091
Q
GWAS1508043_H
ovarian carcinoma QTL GWAS1508043 (human)
IAGP
rs12031579
2.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 1:119,307,920...119,307,921
Q
GWAS1508044_H
ovarian carcinoma QTL GWAS1508044 (human)
IAGP
rs13402729
3.0E-6
GWAS_CATALOG
PMID:31488892
NCBI chr 2:226,482,173...226,482,174
Q
GWAS1518408_H
ovarian carcinoma QTL GWAS1518408 (human)
IAGP
rs17676711
2.0E-7
GWAS_CATALOG
PMID:34290314
NCBI chr 1:192,554,787...192,554,788
Q
GWAS1518415_H
ovarian carcinoma QTL GWAS1518415 (human)
IAGP
rs75453040
8.0E-7
GWAS_CATALOG
PMID:34290314
NCBI chr11:126,209,490...126,209,491
Q
GWAS1518416_H
ovarian carcinoma QTL GWAS1518416 (human)
IAGP
rs75214037
8.0E-6
GWAS_CATALOG
PMID:34290314
NCBI chr12:127,203,336...127,203,337
Q
GWAS1532149_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1532149 (human)
IAGP
rs11621975
5.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr14:101,629,499...101,629,500
Q
GWAS1532150_H
overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1532150 (human)
IAGP
rs202280
6.0E-6
GWAS_CATALOG
PMID:28935272
NCBI chr 8:81,290,982...81,290,983
Q
GWAS1542856_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542856 (human)
IAGP
rs138544011
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 1:203,527,109...203,527,111
Q
GWAS1542857_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542857 (human)
IAGP
rs35568631
6.0E-6
GWAS_CATALOG
PMID:34162658
Q
GWAS1542858_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542858 (human)
IAGP
rs115721567
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 6:21,962,773...21,962,774
Q
GWAS1542859_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542859 (human)
IAGP
rs681304
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 8:101,283,767...101,283,768
Q
GWAS1542860_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1542860 (human)
IAGP
rs11257492
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr10:6,239,119...6,239,120
Q
GWAS1543152_H
progression free survival, ovarian carcinoma QTL GWAS1543152 (human)
IAGP
rs6066569
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr20:47,960,104...47,960,105
Q
GWAS1549164_H
progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1549164 (human)
IAGP
rs17338346
1.0E-5
GWAS_CATALOG
PMID:34162658
NCBI chr X:31,133,020...31,133,021
Q
GWAS1549165_H
progression free survival, ovarian carcinoma QTL GWAS1549165 (human)
IAGP
rs1369564
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:177,846,247...177,846,248
Q
GWAS1549166_H
progression free survival, ovarian carcinoma QTL GWAS1549166 (human)
IAGP
rs146507619
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 5:67,424,965...67,424,966
Q
GWAS1549167_H
progression free survival, ovarian carcinoma QTL GWAS1549167 (human)
IAGP
rs1816300
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 5:97,715,297...97,715,298
Q
GWAS1561958_H
ovarian carcinoma QTL GWAS1561958 (human)
IAGP
rs62274041
5.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 3:156,717,851...156,717,852
Q
GWAS1561959_H
ovarian carcinoma QTL GWAS1561959 (human)
IAGP
rs4691139
4.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 4:164,987,569...164,987,570
Q
GWAS1561960_H
ovarian carcinoma QTL GWAS1561960 (human)
IAGP
rs711830
4.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1561961_H
ovarian carcinoma QTL GWAS1561961 (human)
IAGP
rs6755777
4.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1561962_H
ovarian carcinoma QTL GWAS1561962 (human)
IAGP
rs62274041
5.0E-38
GWAS_CATALOG
PMID:28346442
NCBI chr 3:156,717,851...156,717,852
Q
GWAS1561963_H
ovarian carcinoma QTL GWAS1561963 (human)
IAGP
rs1400482
7.0E-16
GWAS_CATALOG
PMID:28346442
NCBI chr 8:128,529,685...128,529,686
Q
GWAS1561964_H
ovarian carcinoma QTL GWAS1561964 (human)
IAGP
rs144962376
8.0E-10
GWAS_CATALOG
PMID:28346442
Q
GWAS1561965_H
ovarian carcinoma QTL GWAS1561965 (human)
IAGP
rs2165109
8.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 2:111,061,081...111,061,082
Q
GWAS1561966_H
ovarian carcinoma QTL GWAS1561966 (human)
IAGP
rs7953249
6.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr12:120,965,921...120,965,922
Q
GWAS1565616_H
ovarian carcinoma QTL GWAS1565616 (human)
IAGP
rs113732232
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:176,652,990...176,652,991
Q
GWAS1565617_H
ovarian carcinoma QTL GWAS1565617 (human)
IAGP
rs12546957
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 8:127,619,425...127,619,426
Q
GWAS1565618_H
ovarian carcinoma QTL GWAS1565618 (human)
IAGP
rs13420007
6.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:44,110,941...44,110,942
Q
GWAS1565619_H
ovarian carcinoma QTL GWAS1565619 (human)
IAGP
rs140884924
8.0E-6
GWAS_CATALOG
PMID:30898391
Q
GWAS1565620_H
ovarian carcinoma QTL GWAS1565620 (human)
IAGP
rs142825068
8.0E-6
GWAS_CATALOG
PMID:30898391
Q
GWAS1565621_H
ovarian carcinoma QTL GWAS1565621 (human)
IAGP
rs144055451
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr17:28,302,026...28,302,027
Q
GWAS1565940_H
ovarian carcinoma QTL GWAS1565940 (human)
IAGP
rs145022376
1.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr10:1,186,288...1,186,289
Q
GWAS1565941_H
ovarian carcinoma QTL GWAS1565941 (human)
IAGP
rs1934363
3.0E-10
GWAS_CATALOG
PMID:30898391
NCBI chr10:28,484,549...28,484,550
Q
GWAS1565942_H
ovarian carcinoma QTL GWAS1565942 (human)
IAGP
rs7748275
9.0E-9
GWAS_CATALOG
PMID:30898391
NCBI chr 6:3,580,855...3,580,856
Q
GWAS1565943_H
ovarian carcinoma QTL GWAS1565943 (human)
IAGP
rs7748275
4.0E-8
GWAS_CATALOG
PMID:30898391
NCBI chr 6:3,580,855...3,580,856
Q
GWAS1566014_H
ovarian carcinoma QTL GWAS1566014 (human)
IAGP
rs376296328
8.0E-6
GWAS_CATALOG
PMID:30898391
Q
GWAS1566015_H
ovarian carcinoma QTL GWAS1566015 (human)
IAGP
rs3867263
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr18:63,664,376...63,664,377
Q
GWAS1566016_H
ovarian carcinoma QTL GWAS1566016 (human)
IAGP
rs4936453
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr11:111,430,057...111,430,058
Q
GWAS1566017_H
ovarian carcinoma QTL GWAS1566017 (human)
IAGP
rs5932545
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr X:128,926,215...128,926,216
Q
GWAS1566018_H
ovarian carcinoma QTL GWAS1566018 (human)
IAGP
rs5993791
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr22:19,681,497...19,681,498
Q
GWAS1566019_H
ovarian carcinoma QTL GWAS1566019 (human)
IAGP
rs6134303
8.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr20:11,586,401...11,586,402
Q
GWAS1566020_H
ovarian carcinoma QTL GWAS1566020 (human)
IAGP
rs61658193
9.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 9:74,295,221...74,295,226
Q
GWAS1566021_H
ovarian carcinoma QTL GWAS1566021 (human)
IAGP
rs61974021
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr14:26,740,487...26,740,488
Q
GWAS1566022_H
ovarian carcinoma QTL GWAS1566022 (human)
IAGP
rs62397673
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 5:177,806,110...177,806,111
Q
GWAS1566023_H
ovarian carcinoma QTL GWAS1566023 (human)
IAGP
rs7206411
2.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr16:81,619,883...81,619,884
Q
GWAS1566025_H
ovarian carcinoma QTL GWAS1566025 (human)
IAGP
rs169225
7.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr20:22,393,040...22,393,041
Q
GWAS1566026_H
ovarian carcinoma QTL GWAS1566026 (human)
IAGP
rs17057973
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:97,730,186...97,730,187
Q
GWAS1566027_H
ovarian carcinoma QTL GWAS1566027 (human)
IAGP
rs185652178
8.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr 5:147,579,243...147,579,244
Q
GWAS1566028_H
ovarian carcinoma QTL GWAS1566028 (human)
IAGP
rs199256
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:143,007,986...143,007,987
Q
GWAS1566380_H
ovarian carcinoma QTL GWAS1566380 (human)
IAGP
rs200114742
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:14,172,253...14,172,254
Q
GWAS1566381_H
ovarian carcinoma QTL GWAS1566381 (human)
IAGP
rs200529678
5.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 5:87,170,215...87,170,216
Q
GWAS1566382_H
ovarian carcinoma QTL GWAS1566382 (human)
IAGP
rs2119438
6.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 4:64,932,417...64,932,418
Q
GWAS1566383_H
ovarian carcinoma QTL GWAS1566383 (human)
IAGP
rs28568660
2.0E-6
GWAS_CATALOG
PMID:30898391
Q
GWAS1566384_H
ovarian carcinoma QTL GWAS1566384 (human)
IAGP
rs34344307
1.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr16:77,008,511...77,008,512
Q
GWAS1566385_H
ovarian carcinoma QTL GWAS1566385 (human)
IAGP
rs34470775
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 5:165,518,038...165,518,039
Q
GWAS1566386_H
ovarian carcinoma QTL GWAS1566386 (human)
IAGP
rs3754464
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 1:159,009,146...159,009,147
Q
GWAS1566754_H
ovarian carcinoma QTL GWAS1566754 (human)
IAGP
rs73468194
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr X:23,151,499...23,151,500
Q
GWAS1566755_H
ovarian carcinoma QTL GWAS1566755 (human)
IAGP
rs74477043
7.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr10:80,653,667...80,653,668
Q
GWAS1566756_H
ovarian carcinoma QTL GWAS1566756 (human)
IAGP
rs7455465
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 7:34,585,100...34,585,101
Q
GWAS1566757_H
ovarian carcinoma QTL GWAS1566757 (human)
IAGP
rs74828133
6.0E-6
GWAS_CATALOG
PMID:30898391
Q
GWAS1566758_H
ovarian carcinoma QTL GWAS1566758 (human)
IAGP
rs74917072
5.0E-7
GWAS_CATALOG
PMID:30898391
NCBI chr 2:238,022,053...238,022,054
Q
GWAS1566759_H
ovarian carcinoma QTL GWAS1566759 (human)
IAGP
rs75157307
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:18,193,172...18,193,173
Q
GWAS1567075_H
ovarian carcinoma QTL GWAS1567075 (human)
IAGP
rs7559097
6.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 2:38,517,625...38,517,626
Q
GWAS1567076_H
ovarian carcinoma QTL GWAS1567076 (human)
IAGP
rs76731728
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr10:41,850,928...41,850,929
Q
GWAS1567077_H
ovarian carcinoma QTL GWAS1567077 (human)
IAGP
rs77122835
9.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 3:116,459,821...116,459,822
Q
GWAS1567078_H
ovarian carcinoma QTL GWAS1567078 (human)
IAGP
rs78720768
4.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 1:63,315,469...63,315,470
Q
GWAS1567079_H
ovarian carcinoma QTL GWAS1567079 (human)
IAGP
rs79812184
7.0E-6
GWAS_CATALOG
PMID:30898391
Q
GWAS1567080_H
ovarian carcinoma QTL GWAS1567080 (human)
IAGP
rs8060270
3.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr16:73,418,955...73,418,956
Q
GWAS1567081_H
ovarian carcinoma QTL GWAS1567081 (human)
IAGP
rs845930
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr21:31,347,809...31,347,810
Q
GWAS1567082_H
ovarian carcinoma QTL GWAS1567082 (human)
IAGP
rs9382808
2.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 6:60,484,461...60,484,462
Q
GWAS1567083_H
ovarian carcinoma QTL GWAS1567083 (human)
IAGP
rs9442387
8.0E-6
GWAS_CATALOG
PMID:30898391
NCBI chr 1:1,175,206...1,175,207
Q
GWAS1629168_H
ovarian carcinoma, COVID-19 QTL GWAS1629168 (human)
IAGP
rs4962116
4.0E-17
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,254,329...133,254,330
Q
GWAS1629169_H
ovarian carcinoma, COVID-19 QTL GWAS1629169 (human)
IAGP
rs9411395
3.0E-22
GWAS_CATALOG
PMID:37636041
NCBI chr 9:133,317,947...133,317,948
Q
GWAS1629170_H
ovarian carcinoma, COVID-19 QTL GWAS1629170 (human)
IAGP
rs12952950
4.0E-8
GWAS_CATALOG
PMID:37636041
NCBI chr17:45,379,403...45,379,404
Q
GWAS1633773_H
ovarian carcinoma QTL GWAS1633773 (human)
IAGP
rs77235147
7.0E-6
GWAS_CATALOG
PMID:38723632
NCBI chr 8:128,970,485...128,970,486
Q
GWAS1699711_H
cerebrospinal fluid composition attribute, p-tau measurement QTL GWAS1699711 (human)
IAGP
rs6005807
3.0E-7
GWAS_CATALOG
PMID:28346442
Q
GWAS559907_H
ovarian carcinoma QTL GWAS559907 (human)
IAGP
rs12794435
5.0E-6
GWAS_CATALOG
PMID:20852632
NCBI chr11:25,186,158...25,186,159
Q
GWAS560322_H
ovarian carcinoma QTL GWAS560322 (human)
IAGP
rs3814113
6.0E-11
GWAS_CATALOG
PMID:23544013
NCBI chr 9:16,915,023...16,915,024
Q
GWAS568774_H
ovarian carcinoma QTL GWAS568774 (human)
IAGP
rs8170
4.0E-6
GWAS_CATALOG
PMID:20852633
NCBI chr19:17,278,895...17,278,896
Q
GWAS575657_H
ovarian carcinoma QTL GWAS575657 (human)
IAGP
rs3814113
5.0E-19
GWAS_CATALOG
PMID:19648919
NCBI chr 9:16,915,023...16,915,024
Q
GWAS599694_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS599694 (human)
IAGP
rs4808075
2.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr19:17,279,482...17,279,483
Q
GWAS600127_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS600127 (human)
IAGP
rs4808075
4.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr19:17,279,482...17,279,483
Q
GWAS635401_H
ovarian carcinoma QTL GWAS635401 (human)
IAGP
rs8170
3.0E-14
GWAS_CATALOG
PMID:23535730
NCBI chr19:17,278,895...17,278,896
Q
GWAS636026_H
ovarian carcinoma QTL GWAS636026 (human)
IAGP
rs3814113
4.0E-29
GWAS_CATALOG
PMID:23535730
NCBI chr 9:16,915,023...16,915,024
Q
GWAS636101_H
ovarian carcinoma QTL GWAS636101 (human)
IAGP
rs8170
2.0E-7
GWAS_CATALOG
PMID:23535730
NCBI chr19:17,278,895...17,278,896
Q
GWAS636102_H
ovarian carcinoma QTL GWAS636102 (human)
IAGP
rs3814113
4.0E-32
GWAS_CATALOG
PMID:23535730
NCBI chr 9:16,915,023...16,915,024
Q
GWAS656419_H
ovarian carcinoma QTL GWAS656419 (human)
IAGP
rs17631303
1.0E-8
GWAS_CATALOG
PMID:23544013
NCBI chr17:45,439,036...45,439,037
Q
GWAS667804_H
ovarian carcinoma QTL GWAS667804 (human)
IAGP
rs757210
8.0E-10
GWAS_CATALOG
PMID:23535730
NCBI chr17:37,736,525...37,736,526
Q
GWAS669030_H
ovarian carcinoma QTL GWAS669030 (human)
IAGP
rs9303542
1.0E-6
GWAS_CATALOG
PMID:20852632
NCBI chr17:48,334,138...48,334,139
Q
GWAS669031_H
ovarian carcinoma QTL GWAS669031 (human)
IAGP
rs2084881
2.0E-6
GWAS_CATALOG
PMID:20852632
NCBI chr17:48,279,758...48,279,759
Q
GWAS674932_H
ovarian carcinoma QTL GWAS674932 (human)
IAGP
rs2363956
1.0E-7
GWAS_CATALOG
PMID:20852633
NCBI chr19:17,283,315...17,283,316
Q
GWAS688558_H
ovarian carcinoma QTL GWAS688558 (human)
IAGP
rs34289250
6.0E-13
GWAS_CATALOG
PMID:21964575
NCBI chr17:61,803,285...61,803,286
Q
GWAS700893_H
ovarian carcinoma QTL GWAS700893 (human)
IAGP
rs9303542
6.0E-9
GWAS_CATALOG
PMID:23535730
NCBI chr17:48,334,138...48,334,139
Q
GWAS700894_H
ovarian carcinoma QTL GWAS700894 (human)
IAGP
rs9303542
3.0E-10
GWAS_CATALOG
PMID:23535730
NCBI chr17:48,334,138...48,334,139
Q
GWAS700898_H
ovarian carcinoma QTL GWAS700898 (human)
IAGP
rs11782652
6.0E-9
GWAS_CATALOG
PMID:23535730
NCBI chr 8:81,741,409...81,741,410
Q
GWAS700899_H
ovarian carcinoma QTL GWAS700899 (human)
IAGP
rs1243180
2.0E-8
GWAS_CATALOG
PMID:23535730
NCBI chr10:21,626,690...21,626,691
Q
GWAS700900_H
ovarian carcinoma QTL GWAS700900 (human)
IAGP
rs1243180
1.0E-7
GWAS_CATALOG
PMID:23535730
NCBI chr10:21,626,690...21,626,691
Q
GWAS700901_H
ovarian carcinoma QTL GWAS700901 (human)
IAGP
rs11782652
7.0E-10
GWAS_CATALOG
PMID:23535730
NCBI chr 8:81,741,409...81,741,410
Q
GWAS726802_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS726802 (human)
IAGP
rs12601991
7.0E-28
GWAS_CATALOG
PMID:27197191
NCBI chr17:37,741,642...37,741,643
Q
GWAS730995_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS730995 (human)
IAGP
rs12601991
1.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr17:37,741,642...37,741,643
Q
GWAS1117395_H
ovarian clear cell adenocarcinoma QTL GWAS1117395 (human)
IAGP
rs7405776
2.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,733,029...37,733,030
Q
GWAS1117396_H
ovarian clear cell adenocarcinoma QTL GWAS1117396 (human)
IAGP
rs11651755
7.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1018480_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018480 (human)
IAGP
rs11200014
8.0E-35
GWAS_CATALOG
PMID:27197191
NCBI chr10:121,575,416...121,575,417
Q
GWAS1018481_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018481 (human)
IAGP
rs7931342
4.0E-14
GWAS_CATALOG
PMID:27197191
NCBI chr11:69,227,030...69,227,031
Q
GWAS1018549_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018549 (human)
IAGP
rs73110464
2.0E-15
GWAS_CATALOG
PMID:27197191
NCBI chr12:52,918,828...52,918,829
Q
GWAS1018551_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018551 (human)
IAGP
rs11571818
5.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,394,673...32,394,674
Q
GWAS1018552_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018552 (human)
IAGP
rs11844632
3.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr14:68,559,662...68,559,663
Q
GWAS1018620_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018620 (human)
IAGP
rs11907546
3.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,131,991...34,131,992
Q
GWAS1018623_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018623 (human)
IAGP
rs2300206
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,002,002...34,002,003
Q
GWAS1018625_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018625 (human)
IAGP
rs56084662
4.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,295,727...32,295,728
Q
GWAS1018680_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018680 (human)
IAGP
rs11119608
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:210,816,167...210,816,168
Q
GWAS1018681_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018681 (human)
IAGP
rs75316749
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 3:169,043,635...169,043,636
Q
GWAS1018745_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018745 (human)
IAGP
rs4604234
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 6:80,398,959...80,398,960
Q
GWAS1018828_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018828 (human)
IAGP
rs11907546
3.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,131,991...34,131,992
Q
GWAS1018829_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018829 (human)
IAGP
rs2300206
2.0E-8
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,002,002...34,002,003
Q
GWAS1018928_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018928 (human)
IAGP
rs481519
2.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr 3:27,285,723...27,285,724
Q
GWAS1018929_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018929 (human)
IAGP
rs7725218
2.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 5:1,282,299...1,282,300
Q
GWAS1164825_H
lung carcinoma QTL GWAS1164825 (human)
IAGP
rs56404467
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,265,853...32,265,854
Q
GWAS1353931_H
family history of lung cancer QTL GWAS1353931 (human)
IAGP
rs11571833
8.0E-12
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,398,489...32,398,490
Q
GWAS1456967_H
granulocyte count QTL GWAS1456967 (human)
IAGP
rs7679673
1.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 4:105,140,377...105,140,378
Q
GWAS1457463_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457463 (human)
IAGP
rs186507655
5.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 1:1,351,675...1,351,676
Q
GWAS1457536_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457536 (human)
IAGP
rs1862626
4.0E-12
GWAS_CATALOG
PMID:27197191
NCBI chr 5:56,737,113...56,737,114
Q
GWAS1457537_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457537 (human)
IAGP
rs147680653
1.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457538_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457538 (human)
IAGP
rs115707823
5.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457539_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457539 (human)
IAGP
rs115392158
3.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457540_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457540 (human)
IAGP
rs147527678
6.0E-8
GWAS_CATALOG
PMID:27197191
Q
GWAS1457604_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457604 (human)
IAGP
rs1011970
5.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 9:22,062,135...22,062,136
Q
GWAS1457605_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457605 (human)
IAGP
rs148883465
3.0E-8
GWAS_CATALOG
PMID:27197191
NCBI chr11:103,813,371...103,813,372
Q
GWAS1457606_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457606 (human)
IAGP
rs11168936
9.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr12:49,251,457...49,251,458
Q
GWAS1457607_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma QTL GWAS1457607 (human)
IAGP
rs3184504
1.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,446,804...111,446,805
Q
GWAS1457608_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457608 (human)
IAGP
rs1057941
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:155,216,951...155,216,952
Q
GWAS1457609_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457609 (human)
IAGP
rs2974935
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:155,212,052...155,212,053
Q
GWAS1457676_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457676 (human)
IAGP
rs115707823
2.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457677_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457677 (human)
IAGP
rs115392158
9.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457678_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457678 (human)
IAGP
rs147527678
5.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457679_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457679 (human)
IAGP
rs12349081
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 9:21,951,903...21,951,904
Q
GWAS1457680_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457680 (human)
IAGP
rs1011970
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 9:22,062,135...22,062,136
Q
GWAS1457681_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457681 (human)
IAGP
rs3184504
2.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,446,804...111,446,805
Q
GWAS1457776_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457776 (human)
IAGP
rs141752671
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr11:103,745,837...103,745,838
Q
GWAS1457777_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457777 (human)
IAGP
rs11065979
5.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,621,753...111,621,754
Q
GWAS1483225_H
ovarian endometrioid carcinoma QTL GWAS1483225 (human)
IAGP
rs555025179
5.0E-8
GWAS_CATALOG
PMID:28346442
Q
GWAS599694_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS599694 (human)
IAGP
rs4808075
2.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr19:17,279,482...17,279,483
Q
GWAS600127_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS600127 (human)
IAGP
rs4808075
4.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr19:17,279,482...17,279,483
Q
GWAS726802_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS726802 (human)
IAGP
rs12601991
7.0E-28
GWAS_CATALOG
PMID:27197191
NCBI chr17:37,741,642...37,741,643
Q
GWAS730995_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS730995 (human)
IAGP
rs12601991
1.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr17:37,741,642...37,741,643
Q
GWAS1116111_H
ovarian mucinous adenocarcinoma QTL GWAS1116111 (human)
IAGP
rs688187
7.0E-13
GWAS_CATALOG
PMID:26075790
NCBI chr19:39,242,112...39,242,113
Q
GWAS1116129_H
ovarian mucinous adenocarcinoma QTL GWAS1116129 (human)
IAGP
rs688187
1.0E-8
GWAS_CATALOG
PMID:26075790
NCBI chr19:39,242,112...39,242,113
Q
GWAS1117426_H
ovarian mucinous adenocarcinoma QTL GWAS1117426 (human)
IAGP
rs112071820
2.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr 3:139,130,268...139,130,282
Q
GWAS1117428_H
ovarian mucinous adenocarcinoma QTL GWAS1117428 (human)
IAGP
rs11651755
2.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1117509_H
ovarian mucinous adenocarcinoma QTL GWAS1117509 (human)
IAGP
rs320203
2.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 9:102,180,944...102,180,945
Q
GWAS1117511_H
ovarian mucinous adenocarcinoma QTL GWAS1117511 (human)
IAGP
rs688187
1.0E-22
GWAS_CATALOG
PMID:28346442
NCBI chr19:39,242,112...39,242,113
Q
GWAS1428254_H
ovarian mucinous adenocarcinoma QTL GWAS1428254 (human)
IAGP
rs72827480
3.0E-8
GWAS_CATALOG
PMID:38723632
NCBI chr 2:120,388,925...120,388,926
Q
GWAS1483226_H
ovarian mucinous adenocarcinoma QTL GWAS1483226 (human)
IAGP
rs752590
2.0E-12
GWAS_CATALOG
PMID:28346442
NCBI chr 2:113,215,368...113,215,369
Q
GWAS1483227_H
ovarian mucinous adenocarcinoma QTL GWAS1483227 (human)
IAGP
rs711830
1.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1483228_H
ovarian mucinous adenocarcinoma QTL GWAS1483228 (human)
IAGP
rs6755777
1.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1498208_H
ovarian mucinous adenocarcinoma QTL GWAS1498208 (human)
IAGP
rs752590
3.0E-8
GWAS_CATALOG
PMID:26075790
NCBI chr 2:113,215,368...113,215,369
Q
GWAS1498209_H
ovarian mucinous adenocarcinoma QTL GWAS1498209 (human)
IAGP
rs711830
8.0E-12
GWAS_CATALOG
PMID:26075790
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1498210_H
ovarian mucinous adenocarcinoma QTL GWAS1498210 (human)
IAGP
rs72831838
8.0E-7
GWAS_CATALOG
PMID:26075790
NCBI chr 2:113,258,824...113,258,825
Q
GWAS1498211_H
ovarian mucinous adenocarcinoma QTL GWAS1498211 (human)
IAGP
rs711830
8.0E-7
GWAS_CATALOG
PMID:26075790
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1615684_H
ovarian mucinous adenocarcinoma QTL GWAS1615684 (human)
IAGP
rs2594950
7.0E-6
GWAS_CATALOG
PMID:38723632
NCBI chr 2:176,643,894...176,643,895
Q
GWAS1695176_H
ovarian mucinous adenocarcinoma QTL GWAS1695176 (human)
IAGP
rs6470494
6.0E-6
GWAS_CATALOG
PMID:38723632
Q
GWAS1428129_H
ovarian serous adenocarcinoma QTL GWAS1428129 (human)
IAGP
rs1470053
3.0E-6
GWAS_CATALOG
PMID:38723632
NCBI chr 2:111,158,369...111,158,370
Q
GWAS1524125_H
renal carcinoma QTL GWAS1524125 (human)
IAGP
rs2853677
8.0E-10
GWAS_CATALOG
PMID:38723632
NCBI chr 5:1,287,079...1,287,080
Q
GWAS1018480_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018480 (human)
IAGP
rs11200014
8.0E-35
GWAS_CATALOG
PMID:27197191
NCBI chr10:121,575,416...121,575,417
Q
GWAS1018481_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018481 (human)
IAGP
rs7931342
4.0E-14
GWAS_CATALOG
PMID:27197191
NCBI chr11:69,227,030...69,227,031
Q
GWAS1018549_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018549 (human)
IAGP
rs73110464
2.0E-15
GWAS_CATALOG
PMID:27197191
NCBI chr12:52,918,828...52,918,829
Q
GWAS1018551_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018551 (human)
IAGP
rs11571818
5.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,394,673...32,394,674
Q
GWAS1018552_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018552 (human)
IAGP
rs11844632
3.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr14:68,559,662...68,559,663
Q
GWAS1018620_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018620 (human)
IAGP
rs11907546
3.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,131,991...34,131,992
Q
GWAS1018623_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018623 (human)
IAGP
rs2300206
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,002,002...34,002,003
Q
GWAS1018625_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018625 (human)
IAGP
rs56084662
4.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,295,727...32,295,728
Q
GWAS1018680_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018680 (human)
IAGP
rs11119608
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:210,816,167...210,816,168
Q
GWAS1018681_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018681 (human)
IAGP
rs75316749
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 3:169,043,635...169,043,636
Q
GWAS1018745_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018745 (human)
IAGP
rs4604234
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 6:80,398,959...80,398,960
Q
GWAS1018828_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018828 (human)
IAGP
rs11907546
3.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,131,991...34,131,992
Q
GWAS1018829_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018829 (human)
IAGP
rs2300206
2.0E-8
GWAS_CATALOG
PMID:27197191
NCBI chr20:34,002,002...34,002,003
Q
GWAS1018928_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018928 (human)
IAGP
rs481519
2.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr 3:27,285,723...27,285,724
Q
GWAS1018929_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1018929 (human)
IAGP
rs7725218
2.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 5:1,282,299...1,282,300
Q
GWAS1117390_H
ovarian carcinoma QTL GWAS1117390 (human)
IAGP
rs7405776
2.0E-10
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,733,029...37,733,030
Q
GWAS1117424_H
ovarian serous carcinoma QTL GWAS1117424 (human)
IAGP
rs11651755
6.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1117430_H
ovarian serous carcinoma QTL GWAS1117430 (human)
IAGP
rs58722170
2.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 1:37,630,749...37,630,750
Q
GWAS1117504_H
ovarian serous carcinoma QTL GWAS1117504 (human)
IAGP
rs10069690
1.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1117505_H
ovarian serous carcinoma QTL GWAS1117505 (human)
IAGP
rs7705526
2.0E-20
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,285,859...1,285,860
Q
GWAS1117506_H
ovarian serous carcinoma QTL GWAS1117506 (human)
IAGP
rs7405776
1.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,733,029...37,733,030
Q
GWAS1117507_H
ovarian serous carcinoma QTL GWAS1117507 (human)
IAGP
rs7207826
1.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr17:48,423,311...48,423,312
Q
GWAS1117508_H
ovarian serous carcinoma QTL GWAS1117508 (human)
IAGP
rs8098244
4.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr18:23,825,589...23,825,590
Q
GWAS1117512_H
ovarian serous carcinoma QTL GWAS1117512 (human)
IAGP
rs8098244
9.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr18:23,825,589...23,825,590
Q
GWAS1117513_H
ovarian serous carcinoma QTL GWAS1117513 (human)
IAGP
rs58722170
8.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 1:37,630,749...37,630,750
Q
GWAS1117557_H
ovarian serous carcinoma QTL GWAS1117557 (human)
IAGP
rs10069690
5.0E-12
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1117558_H
ovarian serous carcinoma QTL GWAS1117558 (human)
IAGP
rs7705526
2.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,285,859...1,285,860
Q
GWAS1117559_H
ovarian serous carcinoma QTL GWAS1117559 (human)
IAGP
rs10962692
1.0E-47
GWAS_CATALOG
PMID:28346442
NCBI chr 9:16,915,876...16,915,877
Q
GWAS1117560_H
ovarian serous carcinoma QTL GWAS1117560 (human)
IAGP
rs4742903
6.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 9:104,094,512...104,094,513
Q
GWAS1117561_H
ovarian serous carcinoma QTL GWAS1117561 (human)
IAGP
rs8037137
7.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr15:90,963,407...90,963,408
Q
GWAS1117562_H
ovarian serous carcinoma QTL GWAS1117562 (human)
IAGP
rs7405776
3.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,733,029...37,733,030
Q
GWAS1117563_H
ovarian serous carcinoma QTL GWAS1117563 (human)
IAGP
rs11651755
2.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1117564_H
ovarian serous carcinoma QTL GWAS1117564 (human)
IAGP
rs7207826
8.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr17:48,423,311...48,423,312
Q
GWAS1117565_H
ovarian serous carcinoma QTL GWAS1117565 (human)
IAGP
rs4808075
3.0E-26
GWAS_CATALOG
PMID:28346442
NCBI chr19:17,279,482...17,279,483
Q
GWAS1117566_H
ovarian serous carcinoma QTL GWAS1117566 (human)
IAGP
rs1879586
3.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr17:45,489,971...45,489,972
Q
GWAS1117567_H
ovarian serous carcinoma QTL GWAS1117567 (human)
IAGP
rs6005807
1.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr22:28,538,325...28,538,326
Q
GWAS1117568_H
ovarian serous carcinoma QTL GWAS1117568 (human)
IAGP
rs10069690
2.0E-12
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1117569_H
ovarian serous carcinoma QTL GWAS1117569 (human)
IAGP
rs7705526
6.0E-10
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,285,859...1,285,860
Q
GWAS1117623_H
ovarian serous carcinoma QTL GWAS1117623 (human)
IAGP
rs10962692
3.0E-43
GWAS_CATALOG
PMID:28346442
NCBI chr 9:16,915,876...16,915,877
Q
GWAS1117624_H
ovarian serous carcinoma QTL GWAS1117624 (human)
IAGP
rs8037137
1.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr15:90,963,407...90,963,408
Q
GWAS1117625_H
ovarian serous carcinoma QTL GWAS1117625 (human)
IAGP
rs11651755
1.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1117626_H
ovarian serous carcinoma QTL GWAS1117626 (human)
IAGP
rs1879586
3.0E-12
GWAS_CATALOG
PMID:28346442
NCBI chr17:45,489,971...45,489,972
Q
GWAS1117627_H
ovarian serous carcinoma QTL GWAS1117627 (human)
IAGP
rs7207826
1.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr17:48,423,311...48,423,312
Q
GWAS1117628_H
ovarian serous carcinoma QTL GWAS1117628 (human)
IAGP
rs4808075
4.0E-24
GWAS_CATALOG
PMID:28346442
NCBI chr19:17,279,482...17,279,483
Q
GWAS1117629_H
ovarian serous carcinoma QTL GWAS1117629 (human)
IAGP
rs6005807
5.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr22:28,538,325...28,538,326
Q
GWAS1117630_H
ovarian serous carcinoma QTL GWAS1117630 (human)
IAGP
rs13113999
5.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 4:166,265,894...166,265,895
Q
GWAS1117631_H
ovarian serous carcinoma QTL GWAS1117631 (human)
IAGP
rs10069690
4.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr 5:1,279,675...1,279,676
Q
GWAS1117633_H
ovarian serous carcinoma QTL GWAS1117633 (human)
IAGP
rs11651755
5.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr17:37,739,849...37,739,850
Q
GWAS1117634_H
ovarian serous carcinoma QTL GWAS1117634 (human)
IAGP
rs7207826
8.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr17:48,423,311...48,423,312
Q
GWAS1164825_H
lung carcinoma QTL GWAS1164825 (human)
IAGP
rs56404467
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,265,853...32,265,854
Q
GWAS1242108_H
response to gemcitabine QTL GWAS1242108 (human)
IAGP
rs11141915
1.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 9:87,620,879...87,620,880
Q
GWAS1339505_H
progression free survival, ovarian serous carcinoma QTL GWAS1339505 (human)
IAGP
rs35241450
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr22:29,117,567...29,117,568
Q
GWAS1340188_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340188 (human)
IAGP
rs2376820
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 1:3,092,123...3,092,124
Q
GWAS1340189_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340189 (human)
IAGP
rs147138325
1.0E-5
GWAS_CATALOG
PMID:34162658
NCBI chr 1:65,863,804...65,863,805
Q
GWAS1340190_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340190 (human)
IAGP
rs77652838
4.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:47,011,089...47,011,090
Q
GWAS1340191_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340191 (human)
IAGP
rs17018999
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:80,340,409...80,340,410
Q
GWAS1340192_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340192 (human)
IAGP
rs117774911
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:136,288,123...136,288,124
Q
GWAS1340193_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340193 (human)
IAGP
rs74801337
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:76,485,727...76,485,728
Q
GWAS1340194_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340194 (human)
IAGP
rs143886976
4.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:89,297,772...89,297,773
Q
GWAS1340195_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340195 (human)
IAGP
rs59152766
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 5:59,531,580...59,531,581
Q
GWAS1340196_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340196 (human)
IAGP
rs35893266
6.0E-7
GWAS_CATALOG
PMID:34162658
NCBI chr 5:76,450,735...76,450,736
Q
GWAS1340197_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340197 (human)
IAGP
rs7738568
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 6:64,953,580...64,953,581
Q
GWAS1340198_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340198 (human)
IAGP
rs78503057
1.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:23,357,410...23,357,411
Q
GWAS1340199_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340199 (human)
IAGP
rs111401235
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:95,515,509...95,515,510
Q
GWAS1340351_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340351 (human)
IAGP
rs142620543
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 9:12,865,681...12,865,682
Q
GWAS1340352_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340352 (human)
IAGP
rs74865532
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 9:126,858,271...126,858,272
Q
GWAS1340353_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1340353 (human)
IAGP
rs1323657
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr10:6,030,464...6,030,465
Q
GWAS1341204_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341204 (human)
IAGP
rs151311539
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr11:25,650,835...25,650,836
Q
GWAS1341205_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341205 (human)
IAGP
rs11323103
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr11:35,219,864...35,219,865
Q
GWAS1341206_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341206 (human)
IAGP
rs11450161
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr13:35,896,591...35,896,592
Q
GWAS1341374_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341374 (human)
IAGP
rs28538685
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr15:100,153,308...100,153,309
Q
GWAS1341375_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341375 (human)
IAGP
rs35925564
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr16:9,015,221...9,015,222
Q
GWAS1341376_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341376 (human)
IAGP
rs148873983
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr18:65,675,931...65,675,932
Q
GWAS1341377_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341377 (human)
IAGP
rs140397425
5.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr21:38,573,750...38,573,751
Q
GWAS1341378_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341378 (human)
IAGP
rs116481116
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr22:25,815,823...25,815,824
Q
GWAS1341379_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1341379 (human)
IAGP
rs5752640
4.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr22:27,807,762...27,807,763
Q
GWAS1341380_H
progression free survival, ovarian serous carcinoma QTL GWAS1341380 (human)
IAGP
rs183171911
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:36,756,075...36,756,076
Q
GWAS1341381_H
progression free survival, ovarian serous carcinoma QTL GWAS1341381 (human)
IAGP
rs56928399
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 2:80,339,512...80,339,513
Q
GWAS1341382_H
progression free survival, ovarian serous carcinoma QTL GWAS1341382 (human)
IAGP
rs1875108
5.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:55,592,887...55,592,888
Q
GWAS1341383_H
progression free survival, ovarian serous carcinoma QTL GWAS1341383 (human)
IAGP
rs10595258
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 6:48,070,151...48,070,152
Q
GWAS1341384_H
progression free survival, ovarian serous carcinoma QTL GWAS1341384 (human)
IAGP
rs35878068
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:48,200,990...48,200,995
Q
GWAS1341385_H
progression free survival, ovarian serous carcinoma QTL GWAS1341385 (human)
IAGP
rs13238345
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 7:108,471,296...108,471,297
Q
GWAS1342141_H
progression free survival, ovarian serous carcinoma QTL GWAS1342141 (human)
IAGP
rs111774916
6.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 8:53,908,184...53,908,185
Q
GWAS1342142_H
progression free survival, ovarian serous carcinoma QTL GWAS1342142 (human)
IAGP
rs74855156
9.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 9:4,460,023...4,460,024
Q
GWAS1342143_H
progression free survival, ovarian serous carcinoma QTL GWAS1342143 (human)
IAGP
rs202172222
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr15:41,722,120...41,722,121
Q
GWAS1353931_H
family history of lung cancer QTL GWAS1353931 (human)
IAGP
rs11571833
8.0E-12
GWAS_CATALOG
PMID:27197191
NCBI chr13:32,398,489...32,398,490
Q
GWAS1456967_H
granulocyte count QTL GWAS1456967 (human)
IAGP
rs7679673
1.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 4:105,140,377...105,140,378
Q
GWAS1457463_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457463 (human)
IAGP
rs186507655
5.0E-10
GWAS_CATALOG
PMID:27197191
NCBI chr 1:1,351,675...1,351,676
Q
GWAS1457536_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457536 (human)
IAGP
rs1862626
4.0E-12
GWAS_CATALOG
PMID:27197191
NCBI chr 5:56,737,113...56,737,114
Q
GWAS1457537_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457537 (human)
IAGP
rs147680653
1.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457538_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457538 (human)
IAGP
rs115707823
5.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457539_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457539 (human)
IAGP
rs115392158
3.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457540_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457540 (human)
IAGP
rs147527678
6.0E-8
GWAS_CATALOG
PMID:27197191
Q
GWAS1457604_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457604 (human)
IAGP
rs1011970
5.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 9:22,062,135...22,062,136
Q
GWAS1457605_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457605 (human)
IAGP
rs148883465
3.0E-8
GWAS_CATALOG
PMID:27197191
NCBI chr11:103,813,371...103,813,372
Q
GWAS1457606_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457606 (human)
IAGP
rs11168936
9.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr12:49,251,457...49,251,458
Q
GWAS1457607_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma QTL GWAS1457607 (human)
IAGP
rs3184504
1.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,446,804...111,446,805
Q
GWAS1457608_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457608 (human)
IAGP
rs1057941
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:155,216,951...155,216,952
Q
GWAS1457609_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457609 (human)
IAGP
rs2974935
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 1:155,212,052...155,212,053
Q
GWAS1457676_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457676 (human)
IAGP
rs115707823
2.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457677_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457677 (human)
IAGP
rs115392158
9.0E-6
GWAS_CATALOG
PMID:27197191
Q
GWAS1457678_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457678 (human)
IAGP
rs147527678
5.0E-7
GWAS_CATALOG
PMID:27197191
Q
GWAS1457679_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457679 (human)
IAGP
rs12349081
6.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr 9:21,951,903...21,951,904
Q
GWAS1457680_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457680 (human)
IAGP
rs1011970
2.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr 9:22,062,135...22,062,136
Q
GWAS1457681_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457681 (human)
IAGP
rs3184504
2.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,446,804...111,446,805
Q
GWAS1457776_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457776 (human)
IAGP
rs141752671
1.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr11:103,745,837...103,745,838
Q
GWAS1457777_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS1457777 (human)
IAGP
rs11065979
5.0E-6
GWAS_CATALOG
PMID:27197191
NCBI chr12:111,621,753...111,621,754
Q
GWAS1461488_H
ovarian serous carcinoma QTL GWAS1461488 (human)
IAGP
rs57403204
2.0E-7
GWAS_CATALOG
PMID:31469419
NCBI chr X:141,990,766...141,990,767
Q
GWAS1461489_H
ovarian serous carcinoma QTL GWAS1461489 (human)
IAGP
rs66459581
5.0E-7
GWAS_CATALOG
PMID:31469419
NCBI chr17:76,359,183...76,359,184
Q
GWAS1483222_H
ovarian serous carcinoma QTL GWAS1483222 (human)
IAGP
rs9870207
5.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 3:190,807,727...190,807,728
Q
GWAS1483223_H
ovarian serous carcinoma QTL GWAS1483223 (human)
IAGP
rs1400482
1.0E-16
GWAS_CATALOG
PMID:28346442
NCBI chr 8:128,529,685...128,529,686
Q
GWAS1483224_H
ovarian serous carcinoma QTL GWAS1483224 (human)
IAGP
rs7902587
4.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr10:103,934,543...103,934,544
Q
GWAS1483229_H
ovarian serous carcinoma QTL GWAS1483229 (human)
IAGP
rs711830
3.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1483230_H
ovarian serous carcinoma QTL GWAS1483230 (human)
IAGP
rs6755777
2.0E-14
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1483231_H
ovarian serous carcinoma QTL GWAS1483231 (human)
IAGP
rs6755777
6.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1483234_H
ovarian serous carcinoma QTL GWAS1483234 (human)
IAGP
rs150293538
2.0E-9
GWAS_CATALOG
PMID:28346442
NCBI chr 8:76,408,119...76,408,120
Q
GWAS1483449_H
ovarian serous carcinoma QTL GWAS1483449 (human)
IAGP
rs711830
3.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1535271_H
ovarian serous carcinoma QTL GWAS1535271 (human)
IAGP
rs62274041
3.0E-46
GWAS_CATALOG
PMID:28346442
NCBI chr 3:156,717,851...156,717,852
Q
GWAS1535272_H
ovarian serous carcinoma QTL GWAS1535272 (human)
IAGP
rs1400482
2.0E-24
GWAS_CATALOG
PMID:28346442
NCBI chr 8:128,529,685...128,529,686
Q
GWAS1535273_H
ovarian serous carcinoma QTL GWAS1535273 (human)
IAGP
rs144962376
7.0E-9
GWAS_CATALOG
PMID:28346442
Q
GWAS1535274_H
ovarian serous carcinoma QTL GWAS1535274 (human)
IAGP
rs2165109
4.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr 2:111,061,081...111,061,082
Q
GWAS1535278_H
ovarian serous carcinoma QTL GWAS1535278 (human)
IAGP
rs6755777
5.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1535279_H
ovarian serous carcinoma QTL GWAS1535279 (human)
IAGP
rs62274041
4.0E-49
GWAS_CATALOG
PMID:28346442
NCBI chr 3:156,717,851...156,717,852
Q
GWAS1535280_H
ovarian serous carcinoma QTL GWAS1535280 (human)
IAGP
rs1400482
7.0E-22
GWAS_CATALOG
PMID:28346442
NCBI chr 8:128,529,685...128,529,686
Q
GWAS1535281_H
ovarian serous carcinoma QTL GWAS1535281 (human)
IAGP
rs144962376
2.0E-8
GWAS_CATALOG
PMID:28346442
Q
GWAS1535282_H
ovarian serous carcinoma QTL GWAS1535282 (human)
IAGP
rs7953249
8.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr12:120,965,921...120,965,922
Q
GWAS1535360_H
ovarian serous carcinoma QTL GWAS1535360 (human)
IAGP
rs150293538
1.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 8:76,408,119...76,408,120
Q
GWAS1535361_H
ovarian serous carcinoma QTL GWAS1535361 (human)
IAGP
rs711830
5.0E-8
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1535362_H
ovarian serous carcinoma QTL GWAS1535362 (human)
IAGP
rs6755777
3.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,178,498...176,178,499
Q
GWAS1535363_H
ovarian serous carcinoma QTL GWAS1535363 (human)
IAGP
rs711830
8.0E-13
GWAS_CATALOG
PMID:28346442
NCBI chr 2:176,172,583...176,172,584
Q
GWAS1535364_H
ovarian serous carcinoma QTL GWAS1535364 (human)
IAGP
rs9886651
8.0E-6
GWAS_CATALOG
PMID:28346442
NCBI chr 8:127,805,637...127,805,638
Q
GWAS1535365_H
ovarian serous carcinoma QTL GWAS1535365 (human)
IAGP
rs7953249
3.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr12:120,965,921...120,965,922
Q
GWAS1535367_H
ovarian serous carcinoma QTL GWAS1535367 (human)
IAGP
rs1400482
2.0E-12
GWAS_CATALOG
PMID:28346442
NCBI chr 8:128,529,685...128,529,686
Q
GWAS1535368_H
ovarian serous carcinoma QTL GWAS1535368 (human)
IAGP
rs7902587
9.0E-7
GWAS_CATALOG
PMID:28346442
NCBI chr10:103,934,543...103,934,544
Q
GWAS1542861_H
progression free survival, ovarian serous carcinoma QTL GWAS1542861 (human)
IAGP
rs1369564
8.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:177,846,247...177,846,248
Q
GWAS1542862_H
progression free survival, ovarian serous carcinoma QTL GWAS1542862 (human)
IAGP
rs9841147
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 3:197,379,538...197,379,539
Q
GWAS1543149_H
progression free survival, ovarian serous carcinoma QTL GWAS1543149 (human)
IAGP
rs116521001
2.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 4:4,870,660...4,870,661
Q
GWAS1543150_H
progression free survival, ovarian serous carcinoma QTL GWAS1543150 (human)
IAGP
rs1816300
1.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 5:97,715,297...97,715,298
Q
GWAS1543151_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543151 (human)
IAGP
rs6479436
7.0E-7
GWAS_CATALOG
PMID:34162658
NCBI chr 9:92,905,580...92,905,581
Q
GWAS1543153_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543153 (human)
IAGP
rs376435808
1.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr13:24,364,286...24,364,287
Q
GWAS1543154_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543154 (human)
IAGP
rs138082585
4.0E-6
GWAS_CATALOG
PMID:34162658
Q
GWAS1543155_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543155 (human)
IAGP
rs4898923
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr14:57,015,823...57,015,824
Q
GWAS1543156_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543156 (human)
IAGP
rs62337885
7.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 4:173,772,135...173,772,136
Q
GWAS1543157_H
progression free survival, response to carboplatin, ovarian serous carcinoma, trait in response to paclitaxel QTL GWAS1543157 (human)
IAGP
rs7821642
3.0E-6
GWAS_CATALOG
PMID:34162658
NCBI chr 8:19,785,969...19,785,970
Q
GWAS1543165_H
progression free survival, ovarian serous carcinoma QTL GWAS1543165 (human)
IAGP
rs80077319
4.0E-7
GWAS_CATALOG
PMID:34162658
NCBI chr20:24,332,133...24,332,134
Q
GWAS1698914_H
myeloid leukocyte count QTL GWAS1698914 (human)
IAGP
rs7705526
6.0E-19
GWAS_CATALOG
PMID:28346442
Q
GWAS599694_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS599694 (human)
IAGP
rs4808075
2.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr19:17,279,482...17,279,483
Q
GWAS600127_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS600127 (human)
IAGP
rs4808075
4.0E-7
GWAS_CATALOG
PMID:27197191
NCBI chr19:17,279,482...17,279,483
Q
GWAS719484_H
ovarian serous carcinoma QTL GWAS719484 (human)
IAGP
rs37792
6.0E-8
GWAS_CATALOG
PMID:31469419
NCBI chr 5:53,348,817...53,348,818
Q
GWAS719486_H
ovarian serous carcinoma QTL GWAS719486 (human)
IAGP
rs79079890
3.0E-7
GWAS_CATALOG
PMID:31469419
NCBI chr10:3,641,956...3,641,957
Q
GWAS726802_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS726802 (human)
IAGP
rs12601991
7.0E-28
GWAS_CATALOG
PMID:27197191
NCBI chr17:37,741,642...37,741,643
Q
GWAS730995_H
lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma QTL GWAS730995 (human)
IAGP
rs12601991
1.0E-9
GWAS_CATALOG
PMID:27197191
NCBI chr17:37,741,642...37,741,643
Q
GWAS765114_H
ovarian serous carcinoma QTL GWAS765114 (human)
IAGP
rs116046250
9.0E-7
GWAS_CATALOG
PMID:31469419
NCBI chr15:26,986,803...26,986,804
Q
GWAS765115_H
ovarian serous carcinoma QTL GWAS765115 (human)
IAGP
rs192876988
9.0E-7
GWAS_CATALOG
PMID:31469419
NCBI chr 4:79,376,097...79,376,098
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all